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Retinoic acids (RAs) have diverse biologic effects and regulate several cellular 
functions. Here, we investigated the role of RA on autophagy by studying its effects 
on autophagosome (AUT) maturation, as well as on upstream regulators of 
autophagosome biogenesis. Our studies, based on the use of pH-sensitive fluorescent 
reporter markers, suggest that RA promotes AUT acidification and maturation. By 
using competitive inhibitors and specific agonists, we demonstrated that this effect is 
not mediated by the classic Retinoic Acid Receptor (RAR) and Retinoid X Receptors 
(RXR). RA did not affect the protein expression levels of upstream regulators of 
autophagy, such as Beclin-1, phospho-mTOR, and phospho-Akt1, but induced 
redistribution of both endogenous cation-independent mannose-6-phosphate receptor 
CI-MPR and transiently transfected GFP and RFP full-length CI-MPR fusion proteins 
from the trans-Golgi region to acidified AUT structres. Those structures were found 
to be amphisomes (acidified AUTs) and not autophagolysosomes. The critical role of 
CI-MPR in AUT maturation was further demonstrated by siRNA-mediated silencing 
of endogenous CI-MPR. Transient CI-MPR knockdown result d in remarkable 
  
accumulation of nonacidified AUTs, a process that could not be reversed with 
RA.These results suggest that RA induces AUT acidifi at on and maturation by 
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         Eukaryotic cells are equipped with several degradation systems, the 
predominant system being the evolutionarily conserved process of autophagy. Basal 
autophagy plays critical role in cell homeostasis, a  it is responsible for the 
degradation of excessive, malfunctioning and damaged organelles and proteins, and 
whole invading organisms such as bacteria and viruses (Reggiori and Klionsky, 2002 
; Wang and Klionsky, 2003). In addition to basal functions, autophagy provides an 
alternative energy source and a temporary survival mechanism under stress conditions 
(Rajawat and Bossis, 2008). Autophagy is readily induced in response to metabolic 
and endoplasmic reticulum stress, radiation and anticancer drugs, and may play an 
active role in initiating apoptosis and cell death (Yorimitsu et al., 2006; Ito et al., 
2005; Degenhardt et al., 2006; Karantza-Wadsworth et al., 2007; Baehrecke,2005). 
Autophagy is a complex phenomenon controlled by several regulatory proteins and 
signaling pathways. The process relies on formation of double-membrane vesicular 
structures called autophagosomes (AUTs) that engulf the material destined for 
degradation (cargo selection). Initially formed AUTs cannot degrade the selected 
cargo. In subsequent and largely unknown maturation steps, AUTs become acidified, 
lose the inner autophagosomal membrane (amphisomes) or fuse with lysosomes 
(autolysosomes) (Rajawat et al., 2009). The low pH and the presence of hydrolases in 
acidified AUTs, amphisomes and autolysosomes allows for digestion of the cargo 
material. Although this cellular process was initially described over 50 years ago, we 
have only recently started unraveling the basic mechanisms of autophagy and 




Several human diseases are associated with decreased autophagic activity, 
particularly in nondividing cells of the nervous and muscle systems, where turnover 
of intracellular proteins may be critical. Muscular vacuolar disorders (X-linked 
myopathy, inclusion body myositis, and Marinesco-Sjögren syndrome) are associated 
with massive accumulation of imperfect AUTs or lysosomes (Nishino, 2003; Nishino 
et al., 2000; Kalimo et al., 1988; Nonaka, 1999). Danon disease (cardiomyopathy and 
mental retardation) is caused by a deficiency in LAMP-2 which is involved in 
endosomal and lysosomal fusion during the late maturation phase of AUTs (Nishino 
et al., 2000). Reduced autophagic activity and accumulation of protein aggregates is 
also found in neurodegenerative disorders, such as P rkinson's, Alzheimer's, 
Huntington's and transmissible spongiform encephalopathy diseases (Anglade et al., 
1997; Cataldo et al., 1996; Kegel et al., 2000; Liberski et al., 2004). Reduced 
autophagy has also been suggested to increase susceptibility to cancer development 
and progression, however the mechanism is unclear. One could hypothesize that 
perturbations at any stage of AUT formation, maturation, or fusion would result in 
progressive accumulation of aggregated and damaged structures. Those damaged 
components are a likely source of oxidative-stress which in turn results in DNA 
damage and increased tumorigenicity. The prediction w uld then be that induction of 
autophagy may be used for cancer prevention, similarly to the rapidly evolving use of 
autophagy stimulators for prevention of neurodegenerative disorders (Sarkar and 
Rubinsztein, 2008). In addition to the classic aging disorders, autophagy has also 
been implicated in pathogenesis of infectious diseases. In general, autophagy 




(bacteria, parasites, viruses) must actually bypass the autophagic line of defense 
before they can establish infections (Dorn et al., 2002; Tallóczy et al., 2002). Recent 
immunological studies have also indicated the importance of autophagy in antigen 
presentation and successful cellular defense. It can be speculated that the decline in 
autophagic activity with age may contribute to the apparent increased risk of 
infectious disease in the elderly.  
Nutrient availability is one of the best characteriz d factors involved in regulation 
of autophagy. In general, macronutrient (proteins, carbohydrates, lipids) availability 
suppresses autophagy. Macronutrient deprivation and especially reduction in certain 
glucogenic amino acids, mainly glutamine, triggers autophagic protein degradation, 
while the presence of some amino acids (leucine, tyrosine and phenylalanine) is 
sufficient to inhibit autophagy in various cells (Schworer and Mortimore,1979; 
Mordier et al., 2000; Kanazawa et al., 2004). Carbohydrates don’t directly affect 
autophagy; however, they may act indirectly through effects on insulin and insulin 
receptor. Carbohydrates are mostly broken down and become available to cells as 
glucose. An increase in systemic glucose concentration induces insulin secretion 
which causes activation of the insulin receptor and mTOR and suppression of 
autophagy (Ebato et al., 2008). Lipids can affect autophagy indirectly through the 
insulin/glucagon signaling pathway and cholesterol metabolism, or directly, as 
increased intracellular lipid content has been recently shown to impair autophagy 
(Cheng et al., 2006; Singh et al., 2009). With the exception of few reports on vitamin 
D3, E and K2, the effect of micronutrients on autophagy has not been extensively 




leukemia cells with vitamin K2, and MCF-7 breast can er cells with vitamin D3 
induced an increase in the number of AUTs (Høyer-Hansen et al., 2005; Ohtani et al., 
2007; Rickmann et al., 2007; Yokoyama et al., 2008). The mechanism by which 
vitamins E and K2 increased autophagy in the previous studies has not been reported. 
Induction of autophagy by vitamin D3 and analogues wa found to be mediated by an 
increase in intracellular calcium levels which in turn affect the mTOR signaling 
cascade (Høyer-Hansen et al., 2005).  
The importance of VitA as an essential dietary compnent has been recognized a 
century ago (McCollum and Davis, 1913; Osborne and Mendel, 1919). The vitamin is 
essential in several physiological processes such as reproduction, embryonic 
development, tissue remodeling, immune function and vision (Underwood and 
Arthur, 1996; Mangelsdorf et al., 1994). VitA deficiency has been historically 
considered as a nutritionally acquired immunodeficin y disease. Even children who 
are only mildly deficient in VitA have a higher incidence of infectious diseases and a 
higher rate of mortality compared to children who consume sufficient VitA (Field et 
al., 2002). VitA supplementation has been found to decrease both the severity and 
incidence of deaths related to diarrhea and measles in developing countries, where 
vitamin A deficiency is common (West, 2000). The mechanism however by which 
VitA protects against viral and bacterial infections is still unknown. Natural and 
synthetic retinoids are also known to play a major role in regulating cellular growth, 
and differentiation, and can induce apoptosis in a wide variety of malignant cell types 
(Ahuja et al., 1997; Delia et al., 1993; O'Connell et al., 1996). More than 80 years 




metaplasia in the trachea and other epithelial sites that could be reversed by vitamin A 
supplementation (Wolbach et al., 1925). Despite extnsive studies, the mechanism by 
which retinoids suppress tumorigenesis is still largely unknown.  
Retinoids are a class of natural and synthetic vitamin A analogues structurally 
related to All-trans Retinoic Acid (ATRA) and 9-cis-RA (the major active 
metabolites of Vitamin A). Retinoids exert most of their effects by binding to specific 
nuclear retinoic acid receptors (RARs) and retinoid X receptors (RXRs). ATRA binds 
and activates the RAR receptors, while 9-cis-RA binds and activates both RAR and 
RXR receptors (Teboul et al., 2008). Recent evidence though suggests that other 
retinoid response pathways that are independent of the nuclear receptors may exist 
(Mologni et al., 1999; Clifford et al., 1999; Kim et al., 1995). Interestingly, 
photoaffinity labeling studies has shown direct binding of ATRA to the cation-
independent mannose-6-phosphate/IGFII receptor (CI-MPR) with high affinity (Kang 
et al., 1997), however, the binding site for ATRA is not known. CIMPR is a 
ubiquitously and constitutively expressed glycoprotein that plays fundamental role in 
endocytosis and degradation of extracellular ligands (IGF-II, uPAR), lysosomal 
enzyme trafficking and regulation of apoptotic and mitogenic effects (El-Shewy et al., 
2009). The primary function of CIMPR is to sort and transport mannose-6-phosphate 
(M6P) bearing glycoproteins (such as hydrolases) from TGN to 
endosomes/lysosomes., however it is distinct from those for M6P and Insulin like 
Growth Factor –II (IGF-II) on the receptor (El-Shewy et al., 2009).  
Owing to their ability to regulate aberrant cell growth, retinoids are currently being 




and cancer (Altucci et al., 2007; Kast, 2008; Dragnev et al., 2003). In current 
oncologic practice, ATRA is used to induce remission f acute promyelocytic 
leukemia, juvenile chronic myelogenous leukemia and mycosis fungoides. 
Unfortunately, the ability of retinoids to regulate cellular processes in vivo is 
associated with high incidence of undesirable side eff cts. Consequently, aggressive 
use of retinoids in oncology or wider use in other diseases (psoriasis, acne) has been 
precluded by unacceptable side effects including lipid and bone toxicity, visual 
effects, and teratogenicity (Chroni et al., 2010; Moise et al., 2007). Therefore, there is 
a great need to develop new retinoid-related compounds capable of activating 
















Working Hypothesis and Research Objective 
During the last two decades, considerable advances have been made in 
understanding the cellular signaling pathways that regulate autophagy, and 
manipulation of nutrient availability has been the primary experimental methodology 
to study the phenomenon. In this present research we aim to study the regulation of 
Macroautophagy process by retinoids and to determine the effects of dietary VitA on 
autophagy in various stages of development. Pharmacologi al modulation of 
disrupted autophagic activity has been suggested as a strategy for therapies within a 
wide spectrum of pathological situations including cancer, neurological diseases, 
premature aging and infectious diseases. Although retinoids are a multi-targeting 
class of compounds that can modulate several physiological and cellular processes, 
this research study aims to shed light on retinoid regulation of the process of 
Macroautophagy. Novel findings from this study can l y the foundation for the 
development of new and specific retinoid analogues that could enhance or reduce 
autophagic activity.  
Research Objective 
A. Evaluation of the effects of Vitamin A (All-trans Retinoic Acid, ATRA) on 
autophagy in vitro 
A1) Generation of Hela CFP-LC3 (Microtubule associated protein Light 
Chain-3) Stable cell line. 




A3) To evaluate the effect of ATRA treatment on HeLa cells or Stable cell 
line. 
A4) Evaluation of the effect of ATRA treatment on upstream regulator of 
autophagy. 
B) To assess the involvement of receptors in physiologic outcome of ATRA 
treatment on HeLa cells.  
B1) To assess the involvement of classic RAR nuclear r ceptors on biological 
outcome of ATRA treatment on HeLa cells or Stable cell line 
B2) Generation of the GFP and mRFP cation independent mannose-6-
phosphate receptor (CI-MPR) fusion protein and evaluate the effect of ATRA 
treatment on cellular expression or distribution of CI-MPR 

































Intracellular proteolytic systems 
The degradation of intracellular proteins and other cytosolic components plays 
a very important role in the maintenance of intracellular homeostasis, removal of 
damaged and abnormal proteins, cellular differentiation and remodeling, and in 
cellular defense. A balance between protein synthesis and degradation is always 
maintained in eukaryotic and prokaryotic systems (Cuervo, 2004; Goldberg, 2003: 
Ciechanover, 2005; Mizhushima et al., 2008). Perturbation of one of these processes 
can lead to the destruction of the balance and can have a detrimental effect on cell 
survival. Proper turnover (synthesis and degradation) of proteins is essential for 
normal cellular function. Cells contain different proteolytic systems, some of which 
are responsible for general degradation of proteins, while others are involved in 
proteolysis of smaller protein subsets or active only in particular cellular 
compartments. Quantitatively, the most important proteolytic pathways inside cells 
are the ubiquitin-proteasome pathway and the lysosomal pathway. With few notable 
exceptions, most short half-life proteins are degraded by the proteasome, whereas 
most of the long half-life proteins are degraded in lysosomes (Ciechanover, 2005).  
There are various pathways by which lysosomes receiv  the extracellular and 
intracellular material that is to be degraded (Fig.1) (Dice, 2000). Endocytosis can 
internalize extracellular proteins, as well as integral membrane proteins and sequester 
them in endosomes. Subsequently, these endosomes fuse with lysosomes and deliver 
the cargo (Luzio et al., 2007). Crinophagy is the process by which secretory proteins 




Autophagy is the bulk degradation of cytoplasm and organelles by promoting the 
transfer of material  
 
Fig.1 The lysosome-mediated cellular degradative Process: Lysosomes are 
responsible for digestion of both exogenous material and endogenous proteins and 
cellular organelles. Exogenous proteins are targeted to the lysosome through 
phagocytosis, pinocytosis, and receptor-mediated endocytosis. Endogenous proteins 
and cellular organelles are targeted by microautophagy, macroautophagy and 
chaperone-mediated autophagy (CMA). The various intermediate structures and 
organelles (endosomes, autophagosomes, multivesicular bodies) are mostly devoid of 
hydrolases. CMA: chaperone-mediated autophagy. RLC: receptor ligand complex. 





from one, topologically distinct compartment, to another from the cytosol to the 
vacuole in yeast or to lysosomes in eukaryotic cells (Mizushima et al., 2008). 
Chaperone-mediated autophagy (CMA) is a more selective degradation process of 
autophagy in which a specific sequence in the targe substrate protein is recognized 
by cytoplasmic molecular chaperones. Subsequently, the substrate-chaperone 
complex is delivered to lysosome for degradation (Dice, 2007). 
Lysosomes are the major organelles responsible for pr teolytic degradation 
and recycling. The main function of these microscopi  organelles is the digestion of 
macromolecules derived from phagocytosis, endocytosis and autophagy (Fig.1). 
Autophagy is a catabolic process that eliminates aggregates of aberrant proteins, 
superfluous or damaged organelles and sometimes even ntire organisms such as, 
invading bacteria. Although, autophagosomes possess some hydrolytic activity, this 
activity is insufficient to complete proteolytic degradation. Thus, fusion of 
autophagosomes with lysosomes can be viewed as the Achilles heel in the process of 
autophagy. 
Proteasome 
The well-characterized ubiquitin-proteasomal system degrades substrate 
proteins tagged with a poly-ubiquitin chain. Cytosolic proteins destined for 
proteasomal degradation display covalently attached ubiquitin moieties or ubiquitin 
chains linked through the Lysine-48 (K-48) residue of ubiquitin. Ubiquitinization 
involves three sequentially acting enzymes: El which s the ubiquitin activating 




transfers the activated ubiquitin to the substrate. These poly ubiquitinated substrates 
are targeted to the major cytosolic protease, the 26S proteasome, which consists of a 
20S core particle (CP) and a 19S regulatory complex (RP). The 20S CP is a 
proteolytic cylindrical chamber with catalytic sites for different types of proteolytic 
activities required for degradation of the substrate proteins. The 19S regulatory unit 
sits on top of the catalytic core and allows recognitio  of potential targets 
(ubiquitinated proteins).The different subunits of the 19S domain also assist in the 
removal of the ubiquitin from substrate proteins, as well as their subsequent unfolding 
and active internalization into the catalytic chamber (Ciechanover, 2006). The 
ubiquitin-proteasome system plays a critical regulatory role in essential cellular 
processes such as cell division, cell cycle, and cellular differentiation due to its ability 
to rapidly modulate the levels of transcription factors and signaling proteins. 
Autophagy 
Autophagy (derived from the Greek meaning “to eat oneself”) is present in all 
eukaryotic cells and is evolutionarily conserved from yeast to humans (Levine and 
Klionsky, 2004). Autophagy is a ubiquitous catabolic process that involves the bulk 
degradation of cytoplasmic components through a lysosomal pathway. This process is 
characterized by the engulfment of part of the cytoplasm inside double-membrane 
vesicles called autophagosomes. Autophagosomes subsequently fuse with lysosomes 
to form an autophagolysosome in which the cytoplasmic cargo is degraded and the 
degradation products are recycled for the synthesis of new molecules (Lee and 




membranes, and whole organelles, including mitochondria, ribosomes, endoplasmic 
reticulum and peroxisomes, is mediated by autophagy (Cuervo, 2004). The 
autophagic machinery actually mediates the majority of intracellular housekeeping 
tasks. Short-lived nuclear and cytoplasmic proteins are degraded by multicatalytic 
proteinase complexes (proteasomes) and by calcium-dependent neutral proteases 
(calpains). Mitochondria can autonomously turn over c tain defective proteins, 
because they possess their own proteolytic systems (Bakala et al., 2003; Arnold and 
Langer, 2002) 
The cellular process of autophagy was initially described over 50 years ago. 
Only recently though, we have started understanding ts role in various 
pathophysiological conditions and unraveling the basic cell biology mechanism. 
Discovery of the ATG genes in yeast has greatly advanced our understanding of the 
molecular mechanisms involved in autophagosome biogenesis and the various 
pathways that regulate autophagic activity (Suzuki and Ohsumi, 2007). Most yeast 
ATG genes have orthologues, in multicellular organisms (nematodes, flies) and 
mammals, which suggests that the basic machinery fo autophagy has been 
evolutionarily conserved in eukaryotic organisms. These genes, also called 
APG/AUT/CVT, were initially identified from studies that investigated defects in the 
formation of autophagic vacuoles and protein degradation in Saccharomyces 
cerevisiae (Takeshige et al., 1992; Thumm et al., 1994). In these studies, knockout 
strains of individual ATG genes showed defects of starvation-induced autophagy. It is 
now widely accepted that at least 30 yeast genes are actively involved in autophagy. 




key roles in other pathways (Klionsky et al., 2003). The precise cellular and 
biochemical function of these genes in the autophagic pathway remains to be 
elucidated. Although the role of autophagy in the aging process has yet to be fully 
defined, studies in model organisms (C. elegans) and mammals (mice) have begun to 
understand a growing number of aging processes that are influenced by autophagy. It 
is now largely accepted that autophagy affects several cellular activities crucial for 
longevity and healthy aging (eulongevity). 
Types of autophagy 
Eukaryotic cells are equipped with several degradation systems, 
predominantly two proteolytic systems contribute to cellular clearance: the ubiquitin-
proteasome and the lysosomal systems. Autophagy is responsible for the degradation 
of whole organisms and structures (bacteria, viruses), whole organelles, as well as 
long-lived soluble proteins (Reggiori and Klionsky, 2002 ; Wang and Klionsky, 
2003). The differences among the various autophagic me hanisms reside in the type 
of cargo/waste, the route and mechanism for its delivery to lysosomes and the 
physiological conditions in which each process is activ ted. Despite the variety of 
autophagic processes that have been described, they all fall into one of three main 
types: macroautophagy, microautophagy and chaperone-mediated autophagy 






 Chaperone mediated autophagy 
Most eukaryotic cells are equipped with form of autophagy, known as CMA 
(Dice, 2007). CMA is selective for a particular group of soluble cytosolic proteins 
that contain a specific sequence signature. Unlike autophagy, CMA does not require 
intermediate vesicle formation (Majeski and Dice, 2004). Once the specific signature 
sequence is identified, these soluble proteins are directly translocated to the lysosomal 
membrane. The specific signature sequence, which is present in all CMA substrates, 
is biochemically related to the pentapeptide KFERQ (Dice, 1990). All substrates with 
this sequence are then targeted to lysosomes. The cytosolic molecular chaperone heat 
shock protein 70 (hsp70) and its co-chaperones recognize the signature motif in 
substrate proteins (Hayes and Dice, 1996). The substrate/chaperone complex is then 
targeted to the lysosomal membrane, where it binds to a receptor protein, the 
lysosome-associated membrane protein type 2a (LAMP-2a) (Cuervo and Dice, 1996). 
A second chaperone, lysosomal hsc73 (lys-hsc73), is required for complete 
translocation of the substrate protein/hsc70 complex into the lysosomal matrix, where 
it is completely degraded by lysosomal proteases (Trlecky et al., 1992). 
  Microautophagy 
The third form of autophagy is microautophagy (Klionsky, 2005). The 
characteristic feature of the microautophagy process is that the lysosomal membrane 
itself either invaginates or exvaginates to engulf an organelle. Unlike 
macroautophagy, there is no sequestering double-membrane formed in the cytoplasm 




(Kim et al., 2007) involve the selective sequestration or engulfment of peroxisomes 
and mitochondria, respectively, and their delivery to lysosomes. The process of 
microautophagy is poorly characterized, at least in mammalian cells. Variations of 
microautophagy have been described in yeast for the sel ctive degradation of 
peroxisomes (micropexophagy) or even nuclear regions (piecemeal microautophagy) 
(Klionsky et al., 2007). 
 Macroautophagy 
Classic autophagy or macroautophagy is an inducible form of autophagy that 
becomes activated under stress conditions (nutrient deprivation, infections, and 
toxins) (Dice, 2000). Macroautophagy is the most extensively studied and 
quantitatively the most important form of autophagy. In this process, entire regions of 
the cytosol are sequestered by a de novo-synthesized membrane that seals into an 
autophagosome (Fig. 3) (Yorimitsu and Klionsky, 2005). These double-membrane 
vesicles fuse with secondary lysosomes, and in the process, acquire the proteases 
required for degradation of the sequestered material. Two major intracellular kinase 
complexes, the beclin-VPS34 complex and the mTOR (mam alian target of 
rapamycin, as it is referred in mammalian cells) complex, act in coordination to 
modulate formation, circularization, and fusion of the autophagic compartments with 
lysosomes (Yorimitsu and Klionsky, 2005; Ohsumi, 2001). For a long time, 
macroautophagy was considered as an inducible form f autophagy. Growing 
evidence though, indicate the existence of basal macroautophagy, essential for 




et al., 2006 ; Nakai et al., 2007). Here on, in the subsequent text autophagy refers to 
Macroautophagy. 
The (Macroautophagy) Autophagy Process 
The stages involved in the process of autophagy have not as yet been precisely 
delineated, especially for mammalian cells. Studies in the yeast S. cerevisiae have 
provided insight into the mechanisms involved and based on these studies, the 
following steps of autophagy are largely accepted: in uction and cargo selection, 
vesicle nucleation and expansion, lysosome targetin, lysosome docking and 
autophagosome-lysosome fusion, vesicle breakdown and recycling (Klionsky and 
Emr, 2000). 
Autophagy may be either a selective or nonselective process (Reggiori and 
Klionsky, 2005). In S. Cerevisiae, Cvt is a transport mechanism involved in the 
recognition and packaging of cargo and is considered a selective process. However, 
this pathway is limited only to yeast; it is not present in any other organism (Shintani 
and Klionsky, 2004). In general, macroautophagy is considered to be non-specific, 
however there are also specific type of macroautophagy such as in certain cellular 
conditions mitochondria are selectively trapped by autophagosomes. Further some 
types of microbes are selectively killed by autophagy. Growing line of evidence has 
revealed that there are reliable substrate for selective autophagy in mammals such as 
p62 and Nbr1 ( Bjørkøy et al., 2005, Komatsu et al., 2007, Pankiv et al., 2007, 
Ichimura et al., 2008, Kirkin et al., 2009a; Kirkin et al., 2009b). SQSTM1/p62 is the 




ubiquitinated substrates for their degradation via selective autophagy (Bjørkøy et al., 
2005). Recently it has been shown that NBR1 (neighbor of BRCA1 gene 1) also act 
as receptors for selective autophagosomal degradation of ubiquitinated targets (Kirkin 
et al., 2009a). Further, it is proposed that NBR1 toge her with p62 promotes 
autophagic degradation of ubiquitinated targets andsimultaneously regulates their 
aggregation when autophagy becomes limited (Kirkin et al., 2009b). 
At the molecular level, the serine/threonine protein k nase TOR (target of 
rapamycin, as it is referred in yeast) is involved in the induction of autophagy (Petiot 
et al., 2000). Phosphorylated TOR is part of the induction complex and acts as a 
negative regulator of autophagy (Schmelzle and Hall, 2000). Phosphorylated TOR 
negatively controls autophagy, primarily by acting on the signaling cascade that 
controls general translation and transcription. In addition, activated TOR induces 
hyperphosphorylation of Atg13, which lowers its binding affinity to other Atg 
interacting proteins, thereby inhibiting autophagy (Kamada et al., 2000). 
The initial formation of an autophagosomal membrane takes place by 
enwrapping the degradative cargo within a double membrane, which eventually 
elongates to form a vesicle called an autophagosome. The exact origin of 
autophagosomal membranes is controversial. Studies in mammalian cells have 
suggested that autophagosomal membranes originate from the ribosome-free region 
of the rough endoplasmic reticulum (Dunn, 1990). Alternatively, a poorly 
characterized organelle called a phagophore, has also been suggested as the origin of 




unique perivacuolar structure, called PAS (preautophagosomal structure), has been 
proposed as the precursor of autophagosomes due to the transient association of 
several Atg proteins with it (Noda et al., 2002). A P S-like structure has not yet been 
identified in any other endomembrane system (Kim et al., 2002). 
Vesicles will elongate and extremities will fuse to c mplete the double-
membraned structure. Phagophores elongate and completely encircle the cargo to 
form an “autophagosome” or “autophagic vacuole” (Fig. 3) (Reggiori and Klionsky, 
2002). Most of the proteins involved in vesicle expansion and maturation steps are 
retrieved to the original pool because they do not associate with the complete and 
mature autophagosome (Levine and Klionsky, 2004, Reggiori and Klionsky, 
2002 ; Klionsky, 2005). Therefore, it has been suggested that the proteins involved in 
autophagosome formation are retrieved for future use. Atg8 (LC3) is the exception; it 
is found on the mature autophagosome and can be used as a valuable marker to track 
these structures (Ohsumi, 2001). 
The next critical step is transport and fusion of the autophagosome with the 
lysosomes. The outer membrane of the autophagosome c pletely fuses with the 
outer membrane of the lysosome to make a path for the inner membrane bound 
autophagic vacuole. The inner membrane and its enclosed cytoplasmic contents, 
which together are called an “autophagic body”, are rel ased into the lumen of the 
lysosome (Fig. 3). The machinery required for the process of vesicl fusion includes 
SNARE proteins and the class C Vps/HOPS complex (Wang and Klionsky, 2003). 




content by lysosomal enzymes, which ensures recycling of essential cytoplasmic 
contents. 
Molecular Regulation of Macroautophagy 
Regulation of autophagosome biogenesis, maturation, and fusion with lysosomes 
is a complicated process and a number of diverse signaling complexes and pathways 
are involved (Fig. 2). Induction of autophagosome biogenesis requires two
complexes. The first one, that initiates vesicle formation, contains the Class III PI3K 
(Vps34), Beclin1/Atg6, Atg14 and Vps15/p150. The second one, responsible for the 
vesicle nucleation, contains Atg1, Atg11, Atg13 and Atg17, the association of which 






Fig.2 Regulation of autophagy: important pathways regulating autophagy includes 
TOR (target of rapamycin), which is at the center of the diverse pathways linked to 










Nutrient starvation or treatment of yeast cells with rapamycin (a specific inhibitor of 
TOR) rapidly induces an increase in autophagosome formation (Beck and Hall, 
1999). Inhibition of TOR results in dephosphorylation of Tap (Klionsky et al., 2003) 
causing its dissociation from PP2A. PP2A becomes activated, causing 
dephosphorylation of downstream targets and activation of Atg1. In mammalian cells, 
mTOR appears to modulate autophagy in a manner similar to that observed in yeast. 
Likewise, the activity of the mammalian PP2A orthologue is strongly correlated to 
induction of autophagy (Holen et al., 1992). 
The observation that 3-methyladenine (PI3K inhibitor) inhibits autophagy was 
the first evidence that implicated the Vps34/class III PI3K family of kinases in the 
process (Seglen and Gordon, 1982). In addition, other PI3K inhibitors, such as 
wortmannin and LY294002, have also been found to inhib t autophagy. In yeast, 
Vps34 is primarily involved in vacuolar protein targeting, through the 
endosomal/prevacuolar compartment, to form a complex with Vps15-Vps38-Atg6 
(Kihara et al., 2001a). At the same time, Vps34 has been found to associate with 
Vps15-Atg6-Atg14 on pre-autophagosomal structure (PAS) or phagophore assembly 
site (Obara et al., 2006). PAS is a perivacuolar site where transient accumulation of 
most of the Atg proteins takes place and considers as autophagosomes origin site 
(Suzuki et al., 2001). Atg 14 and Atg 6 are important in mediating the localization of 
other Atg protein to the PAS (Suzuki et al., 2007). However, the mechanism by which 
Vps34 affects autophagosome formation is largely unknown. In mammalian cells, 
there are three classes of PI3Ks. So far, only Class I and Class III PI3K have been 




(Petiot et al., 2000) Class III PI3K has been found to associate with beclin-1 and 
p150, which are the orthologues of yeast Atg6 and Vps15, respectively. Class III 
PI3K regulates diverse molecular pathways, including several involved in tumor 
formation. 
The first autophagy-related tumor suppressor gene rported was Beclin-1, the 
mammalian orthologue of yeast Atg6, which showed a relationship between 
autophagy and cancer (Liang et al., 1999). Beclin 1 was identified as a new binding 
partner for Bcl-2 by Liang et al using yeast two-hybrid system (Liang et al., 1998) 
and later on Beclin 1 was the first protein shown to indispensible for autophagy 
(Liang et al., 1999). Beclin1/Vps34 complex produces Phosphatidylinositol-3-
phosphate which is an early step in the autophagosome formation (Kihara et al., 
2001b). This step is important for the recruitment of other ATG proteins. Afterwards, 
the sequential recruitment of ATG12 and its covalent bi ding with the ATG5 pool on 
the isolation membrane triggers autophagosome formation. Now, ATG12–ATG5 
conjugate binds with ATG16 and this trimeric complex oligomerizes and localize on 
the external surface forming the autophagosome (Fig. 3). ATG12–ATG5–ATG16 and 
other ATG complex signals the recruitment of LC3 (ATG8) and forms ATG12–
ATG5 and LC3 conjugate. Interaction of Beclin 1 with Vps34 and Vps15 is 
conserved in mammals (Kihara et al., 2001b). Additionally, Beclin 1 interacts with 
UVRAG (the UV irradiation resistance-associated gene protein) (Liang et al., 2006), 
Ambra1 (activating molecule in Beclin 1-regulated autophagy) (Fimia et al., 2007) 




Bif-1 are all positive regulator of autophagy and iispensable for the activation of 
autopagy, as well as for the optimal activation of Vps34. 
 
 
Fig.3 Process of Autophagy: Autophagosome Biogenesis, Lysosomal fusion and 
interaction of Autophagy genes (ATG) at various step . LC3 (ATG8) is well known 







In yeast, Atg1 is involved in both the Cvt and autophagic pathways, and it is 
found in association with Atg11 and Atg 13 (Kamada et al., 2000). Under nutrient-
rich conditions, TOR activation causes hyperphosphorylation of Atg13 that prevents 
its association with Atg1 and it enables interaction of Atg1 with Atg11; this may 
determine the use of the autophagic machinery in the Cvt pathway. Under nutrient 
starvation or treatment with rapamycin, Atg13 becomes partially dephosphorylated, 
leading to an Atg1–Atg13 interaction, which subsequently triggers autophagy and 
generation of autophagosomes instead of Cvt vesicles. Atg17 is an Atg13 interacting 
protein that is part of the Atg1 complex and modulates the kinase activity of Atg1 
(Kamada et al., 2000). Recently, hierarchy map analysis of Atg proteins involved in 
PAS organization has suggested that phosphorylated Atg 17 is the most basic protein 
in PAS organization: when it is specifically targeted to the plasma membrane, other 
Atg proteins are recruited to that location, suggesting that Atg17p acts as a scaffold 
protein to organize Atg proteins to the PAS (Suzuki et al., 2007). 
In yeast, vesicle expansion and maturation is controlled by two ubiquitin like 
conjugation complexes; the Atg12–Atg5 conjugation cmplex and the Atg8 lipidation 
complex. In mammalian cells, the Atg8 orthologue MAP-LC3 (microtubule-
associated protein light chain 3) is associated with GATE-16 (Golgi associated 
ATPase enhancer of 16 kDa) and GABARAP (γ-aminobutyric acid type A receptor-
associated protein) (Okazaki et al., 2000). This complex was found to interact with 
ULK1, the mammalian orthologue of Atg1 (Yan et al., 1998). GATE-16 and 
GABARAP are the other two mammalian Atg8 orthologues. For vesicle expansion, 




cysteine protease Atg4. This cleavage exposes a reactiv  glycine in the C-terminus of 
Atg8 (MAP-LC3-I) that is subsequently activated by the Atg3 and Atg7 enzymes, and 
covalently linked to phosphatidylethanolamine (MAP-LC3-II-PE) on the 
autophagosomal membrane. This action of Atg3 and Atg7 requires activation by the 
Atg12–Atg5–Atg16 conjugation system, which dissociates from the membrane once 
autophagosome maturation is completed. The subsequent f sion with the lysosome 
(vacuole in yeast) leads to engulfment of the autophagosome, breakdown of its 
internal membrane and degradation of its cytosolic content by the action of lysosomal 
hydrolases. 
Nutrient regulation of Macroautophagy 
A host of dietary factors can influence various cellular processes and thereby 
potentially influence overall cancer risk and tumor behavior (Singletary and Milner, 
2008). A wealth of evidence links diet habits and the accompanying nutritional status 
with cancer risk and tumor behavior (Popkin, 2007; Thomasset et al., 2007; 
Singletary et al., 2005). Characterizing how essential and nonessential dietary 
constituents can modulate single or multiple hallmark processes of carcinogenesis 
(Hanahan and Weinberg, 2000) is fundamental to identifying more effective 
mechanistic-based strategies for cancer prevention and therapy. To date, numerous 
structurally diverse biologically active food components have been reported to 
interfere with intercellular and intracellular signaling pathways that may activate 
critical cellular proto-oncogenes or inactivate tumor suppressor genes (Singletary et 




modify growth autonomy, proliferation, angiogenesis, and metastasis and dysregulate 
cellular processes. Furthermore, a host of dietary f ctors can stimulate programmed 
cell death (Martin, 2006). 
 In this regard, it is now apparent that the demise of cancer cells not only can 
follow the well-characterized type I apoptotic pathway but also can proceed by 
stimulation of nonapoptotic modes such as type II (macroautophagy-related) and type 
III (necrosis) or combinations thereof (Ricci and Zong, 2006; Leist and Jaattela, 2001; 
Lockshin and Zakeri, 2004). However, in contrast to apoptosis, the induction of 
macroautophagy may contribute to either cell survival or death in response to a 
stressor. As described in more detail in above sections, autophagy is a degradative 
process by which cytoplasmic constituents of cells are engulfed within a cytoplasmic 
vacuole and delivered to the lysosome for degradation. Paradoxically, depending on 
the circumstances, this process of “self-consumption” may be involved in both health 
and disease progression (Shintani and Klionsky, 2004; Levine and Kroemer, 2008; 
Mizhushima et al., 2008; Krysko et al., 2008; Eskelinen et al., 2005). 
The canonical up-regulator of autophagy is nutrient deprivation and starvation 
(Kadowaski et al., 2006). Thus, autophagy is sensitive to levels of nutrients such as 
amino acids and glucose; hormones such as insulin and glucagon; and growth factors 
and cytokines such as insulin-like growth factor I, TNFα, and interleukin-3 
(Tsujimoto and Shimizu, 2005). A coordinated response to nutrient (particularly 
amino acid) deprivation is regulated in mammals largely by cellular “nutrient 




mammalian TOR (mTOR) kinase is a repressor of autophagy and is an important 
controller of cell growth and proliferation. Therefore, it is not surprising that it is 
regulated by and communicates with multiple signaling pathways (Fingar and Blenis, 
2004; Bhaskar and Hay, 2007; Sarbassov et al., 2005; Feng et al., 2005; Dann et al., 
2007; Feng et al., 2007; Pattingre et al., 2008). 
Another sensor of cellular bioenergetics, specifically in response to energy 
depletion, is the AMP-activated protein kinase (AMPK). AMPK is an activator of 
tuberous sclerosis complex 1/2, which, as a suppresso  of mTOR, increases 
autophagy. Decreased energy availability leading to an increased intracellular 
AMP/ATP ratio results in activation of AMPK, in part, via the upstream kinase 
activities of the tumor suppressor LKB1 and Ca2+/calmodulin kinase kinase β (Liang 
et al., 2007; Hoyer-Hansen and Jaattela, 2007; Hardie et al., 2007). There is also 
emerging evidence that other signal transduction pathw ys may regulate autophagy in 
a cell-specific manner. Thus nutrient status and metabolic stressors can influence the 
autophagic response via signaling networks that often, but not exclusively, converge 
at mTOR and that include both oncogene- and tumor suppressor gene–regulated 
intermediate steps. 
Functions of autophagy  
Autophagy is evolutionary conserved cellular catabolic process in eukaryotes 
which is required to maintain cellular homeostasis. Autophagy is responsible for the 
turnover of most long-lived proteins, macromolecules, protein aggregates, misfolded 




normal conditions and in important for maintaining i tracellular housekeeping task 
which are require for cellular homeostasis. However, during stress, such as nutrient 
starvation, autophagy can also be induced as a way to produce nutrients for the 
cellular survival. So it helps cellular adaptation t  nutrient deprivation. So in a normal 
cell autophagy regulates energy homeostasis and protein and organelle quality 
control. In multicellular eukaryotes autophagy is involved in plethora of functions 
(along with above described functions). Autophagy is required for protection against 
pathogens (intracellular virus and bacteria), a mean for antigen presentation, act as 
innate immune response and autophagy proteins play crucial role in immunity and 
inflammation. Autophagy also plays a crucial role in neonatal development, ageing, 
neurodegeneration, cell death (Excessive cannibalism of cells own constituents) and 
cancer. So in conclusion, autophagy can act as a cytoprotective mechanism to prevent 
various diseases, and dysfunctional autophagy leads to pathology.   
Recent advances in the molecular characterization of aut phagy have allowed 
the development of knockout and transgenic models that enable now to analyze the 
physiological role of autophagy. The classical role described for autophagy in the 
cellular adaptation to starvation has now been confirmed in the knock-out models for 
different essential autophagy genes (Kuma et al., 2004). Autophagy is thus required 
as a main source of both amino acids and energy in basal conditions as well as under 
stress. In this respect, macroautophagy and CMA seem to fulfill complementary 
functions. Thus, macroautophagy is maximally activated in different cell types during 
the first hours of starvation but it is gradually replaced by activation of CMA as 




novel functions for the autophagic system, most of them revolving around the ability 
of this pathway to eliminate damaged structures inside cells. This clearance has 
proven to be essential in maintenance of cellular homeostasis in many organs and 
tissues (Komatsu et al., 2005; Komatsu et al., 2006; Hara et al., 2006, Nakai et al., 
2007.Different studies support an important role for CMA in the removal of altered 
proteins, (Cuervo, 2004; Massey et al., 2006; Wing et al., 1991; Cuervo and Dice, 
1999) however, removal of damaged organelles and protein aggregates can only be 
attained via macroautophagy (Lemasters,2005; Yorimitsu et al., 2006; Iwata et al., 
2005 Rubinsztein et al.,2005). 
Recently, a tight connection between autophagy and cell death has also been 
proposed. Although based on morphological descriptions, autophagy has been 
categorized as type II cell death (or non-apoptotic), he evidence supporting an active 
role of autophagy in cell death is still not clear (Debnath et al., 2005). In most 
conditions, macroautophagy has been shown to play a protective role against different 
types of stressors and thus act as a mechanism of cell defense rather than cell death, 
(Cuervo, 2004; Levine 2005; Levine 2007) and this seems to hold true for CMA ( 
Massey et al., 2006) as well. It is only under conditions in which autophagy does not 
succeed in its attempts to protect cells against internal or external aggressors that the 
autophagic pathway itself fails and cellular death results. There are, however, 
nstances in which uncontrolled activation of autophagy has been shown to result in 
cell death (Pattingre et al., 2005). 
Autophagy, and in particular macroautophagy, has been shown to play a 




embryogenesis (Fimia et al., 2007; Qu et al., 2007; Tsukamoto et al., 2008). 
Furthermore, functional autophagy is essential in the cellular defense against 
pathogens (virus, bacteria, etc.). In fact, xenophagy was the term coined to refer to the 
engagement of autophagic machinery for the degradation of extracellular pathogens 
(Levine, 2005; Paludan et al., 2005). Both macroautphagy and CMA have also been 
shown to participate in the processing of exogenous antigens and autoantigens for 
presentation via MHC class II complexes to be destroyed by recognition via CD4+ T 
cells (DengJel et al., 2005; Zhou et al., 2005).  
In conclusion, the different forms of autophagy participate as effectors or 
regulators of a growing number of cellular and organismal functions, reinforcing, 
thus, the physiological importance of this process. Al o, various autophagy knockout 
and transgenic models that have provided invaluable information about the 
physiological functions of autophagy have also helped to establish connections 
between autophagy and different diseases. 
Autophagy in diseases  
Several human diseases are associated with decreased autophagic activity, 
particularly in nondividing cells of the nervous and muscle systems where turnover of 
intracellular proteins may be critical (Rajawat et.al , 2008). Muscular disorders, 
known as vacuolar myopathies, are associated with massive accumulation of 
imperfect autophagic or lysosomal vacuoles (Nishino, 2003). Danon disease is 
characterized by cardiomyopathy and mild mental retardation and is caused by a 
deficiency in LAMP-2, the transmembrane protein involved in endosomal and 




al., 2000). Accumulation of aberrant autophagosomes has also been associated with 
X-linked myopathy (X-MEA), inclusion body myositis and Marinesco-Sjögren 
syndrome (Kalimo et al., 1988; Nonaka, 1999; Goto et al., 1990). 
 Reduced autophagic activity is also associated with neurodegenerative 
disorders, such as Parkinson's (PD), Alzheimer's (AD), Huntington's (HD), and 
transmissible spongiform encephalopathy (prion disease) (Anglade et al., 1997; 
Cataldo et al., 1996Kegel et al., 2000; Liberski, 2004) Altered activity of proteolytic 
systems and the occurrence of intracellular protein aggregates (inclusion bodies) are 
characteristic of these neurodegenerative diseases. The protein that accumulates in 
PD is mutated α-synuclein, in HD the protein is an abnormally expanded form of 
huntingtin, and in AD, protein deposits of overproduced β-amyloid precursors 
respectively (Stefanis et al., 2001; Venkataraman et al., 2004). Reduced autophagy 
has also been associated with chronic liver disease and hepatocellular carcinoma due 
to retention of mutant alpha (1)-Anti-Trypsin Z (ATZ) protein in the ER and 
mitochondria of hepatocytes (Teckman et al., 2004). One could hypothesize that 
perturbations at any stage of autophagosome biogenesis, maturation, or fusion with 
lysosomes would result in progressive accumulation of these aggregates and lead to 
disease progression. 
  In addition to the classic aging disorders and those of premature aging, 
autophagy has also been implicated in pathogenesis of infectious diseases. In general, 
autophagy functions as a protective mechanism against infections. Most foreign 




defense before they can establish infections. In certain cases, some microorganisms 
have developed strategies to manipulate the autophagic machinery to their own 
advantage. After escaping the endophagocytic pathway and preventing fusion with 
lysosomes, the bacterium Brucella abortus shelters and replicates itself in 
autophagosome-like vesicles (Dorn, 2008). Legionella pneumophila secretes a 
product that activates autophagy and allows it to replicate itself directly inside 
autolysosomes (Coers, 2000). Likewise, a virulence protein, ICP34.5, in the Herpes 
simplex virus antagonizes the autophagic pathway and allows the virus to escape 
degradation (Tall et al., 2002). Recent immunological studies have also indicated the 
importance of autophagy in antigen presentation and successful cellular defense. It 
can be speculated that the decline in autophagic activity with age may contribute to 
the apparent increased risk of infectious disease in the elderly. 
Since autophagic elimination of aggregated proteins a d damaged organelles 
preserves cells from further damage, autophagy could serve a protective role. 
Enhancement of autophagic activity in aging organisms can have preventive or 
therapeutic potential. Caloric restriction-induced autophagy has a well-documented 
effect in extending life expectancy, at least in lower eukaryotic organisms and some 
laboratory mammals (Bergamini et al., 2004). The mTOR inhibitor and autophagy 
promoter, rapamycin, has shown promising anticancer activity in clinical trials 
(Guertin and Sabatini, 2005). Bacterial and viral proteins that modify autophagosome 





Autophagy and neurodegeneration  
Autophagic dysfunction has been described as one of the bases of 
pathogenesis in a growing number of neurodegenerativ  disorders. The main reason 
for this relationship is the fact that most neurodegenerative disorders can indeed be 
classified under the category of protein conformational disorders, a subset of diseases 
which result from the accumulation of misfolded proteins inside cells. Protein 
misfolding in these diseases can result from either mutations or post-translational 
modification by intra- and extracellular stressors. These misfolded proteins often 
organize into insoluble toxic oligomers and aggregat s which accumulate inside cells 
as inclusion bodies.  
Chaperones and the ubiquitin/proteasome system have been shown to be the 
first line of defense against these misbehaving proteins. In recent years, a role for 
CMA in the handling of altered proteins when still in a soluble form has also been 
demonstrated( Cuervo et al., 2004; Martinez-Vicente et al., 2008). Failure of any of 
these two defensive mechanisms leads to upregulation of macroautophagy, the only 
proteolytic pathway able to engulf and remove insoluble protein aggregates (Iwata et 
al., 2005; Ravilumar et al., 2002). Macroautophagy is thus responsible for the 
compensatory state in which cell viability is preserved through the activation of this 
pathway. However, as levels of misbehaving proteins continue to increase gradually, 
the constitutive activation of macroautophagy becomes insufficient to preserve a 
stable proteome. The decreased function of this autophagic system is often the 
consequence of direct blockage by misfolded or altered proteins but aggravating 




The inability to maintain the autophagic response leads to accumulation of the altered 
proteins, partially undigested products, and cytosolic vesicles, which alter normal 
cellular function. Eventually, by mechanisms which are still unclear, these conditions 
result in cell death (Bandhyopadhyay and Cuervo, 2006).  
Although the participation of autophagy in neurodegeneration requires more 
extensive investigation, the molecular basis for the autophagic dysfunction in some of 
these diseases has started to be elucidated. Thus, in the case of AD, the toxic protein 
product (A-beta) seems to interfere with the ability of lysosomes to clear up 
autophagic vacuoles formed in the cytosol of affected neurons. Upregulation of the 
endocytic-lysosomal system becomes evident in the affected brain regions at very 
early stages, which has been interpreted as a mechanism to cope with the fusion 
problem between autophagic vacuoles and lysosomes (Yu et al., 2005). As the disease 
progresses, lysosomal efficiency decreases. At the final stage, lysosomal leakage of 
proteolytic enzymes can be seen, which is detrimental for the affected neurons 
(Nixon, 2006; Nixon et al., 2000). The molecular basis for CMA failure in familial 
forms of PD has also been investigated. In this case, pathogenic forms of a-synuclein, 
one of the proteins that accumulate in the inclusion b dies of affected neurons, 
directly interfere with the ability of lysosomes to internalize cytosolic proteins via 
CMA. Mutant and post-translational forms of a-synuclein bind with abnormally high 
affinity to the CMA receptor at the lysosomal membrane, thus blocking this type of 






Autophagy and infectious diseases  
The recently described role for autophagy in innate and adaptive immunity 
has led to the identification of a failure in proper autophagic function as the basis for 
some infectious diseases. Although certain intracellular pathogens are killed by 
autophagy, several others can use the autophagic compartments for their own benefit 
as sites for survival and replication. For example, after intracellular uptake, Brucella 
abortus and Porphyromonas gingivalis transit from early autophagosomes to late 
autophagosomes and prevent the formation of autolysosomes, either by delaying the 
autophagosome-lysosome fusion or by redirecting the normal autophagic trafficking. 
Survival of P. gingivalis through subversion of the host autophagic pathway can be 
viewed as a bacterial strategy to evade the innate immune system and persist in the 
host( Rodrigues et al., 2008). Another bacterium, Legionella pneumophila, seems to 
reach autolysosomes that already contain lytic enzymes and replicates there. The 
hydrolases of the host are, in this case, the ones processing the sequestered products 
to provide energy for the pathogen. An interesting finding in this case, is that 
autophagy is directly activated by a product secretd by the bacteria. If secretion in 
bacteria is blocked, autophagy is no longer stimulated and the bacteria are destroyed 
in phagolysosomes (Swanson and Isberg, 1995). Similar strategies are used by other 
bacterial pathogens and viruses (Levine and Deretic, 2007). 
Autophagy and Immunity  
Autophagy is considered as important arm of innate immune response. 
Autophagy is involved in the engulfment of intracellular viruses for their degradation 




clearance, regulation of inflammatory cytokine production, regulation of type 1 
interferon production. Additionally, autophagy genes are involved in the generation 
of both innate and adaptive immune responses. Autophagy and/or autophagy genes 
also play a role in delivering ligands (VSV and Sendai virus) to TLRs for their 
activation. Activation of specific TLRs (TLR7 and TLR3) also initiates autophagy in 
some cells. Autophagy activation after TLR stimulation presumably functions to 
mediate xenophagy of entering pathogen. Up regulation of autophagy downstream of 
TLR stimulation may also enhance innate immune respon es independently of 
xenophagy.  
Autophagy participates in several aspects of immunity encompassing 
functions of the entire immune system to cell autonomous mechanisms. Autophagic 
mechanisms governing entire immune system function ra ge from T cell 
development to generation of adaptive immune response. Indeed, autophagy within 
thymic epithelial cells is necessary for proper positive and negative selection of CD4 
and CD8 T cell development (Nedjic et al, 2008). Furthermore, autophagy is required 
for CD4 T cell homeostasis. IL-7 stimulation of CD4 T cells provides important 
activation of mTOR resulting in inhibition of autophagy and cell proliferation. Lack 
of IL-7 signaling yields autophagy engagement and results in type II programmed cell 
death (Nedjic et al, 2008). Autophagy has also been implicated in the generation of an 
adaptive immune response. Essential to the developmnt of an adaptive immune 
response is the ability for MHC class I and II to load and present antigenic peptides to 
CD8+ and CD4+ T cells (respectively). The MHC II machinery contained within 




then trafficked through the endocytic pathway to present MHC II: peptide on the 
surface of the cell for CD4+ T cell recognition. In certain cases, autophagy assists 
with deliverance of antigenic peptides to MHC II compartments to further CD4 T cell 
response (Kasai et al., 2009; Schmid et al., 2007; Paludan et al., 2005). Autophagy 
has also been reported to intersect with the cellular mechanism of cross-processing of 
MHC I antigen and suggested to be important for cross-presentation of infectious or 
tumor antigens (English et al., 2009; Li et al., 2008; Uhl et al., 2009). Together, these 
studies suggest that autophagy is necessary for generation of adaptive immunity and 
host protection; furthermore, autophagy aided antige  presentation may have 
implications for vaccine development (Lee et al., 2010; Jagannath et al., 2009). 
Autophagy is under strict regulation to aid in defens  against intracellular 
pathogens. Importantly, autophagy engagement must be a precisely regulated and 
controlled process in order to elicit immune function and avoid risk of autophagic cell 
death. Therefore, autophagy must undergo counter regulation to maintain a balance. 
Autophagy has been described as a mechanism that delivers several pathogens to 
lysosomes for killing. Indeed, autophagic degradation has been reported to target 
vacuolar and cytoplasmic pathogens including herpes simplex virus (HSV), human 
cytomegalovirus (HCMV), Group A Streptoccocus, Mycobacterium tuberculosis, 
Listeria monocytogenes, Salmonella typhurmium, Rickettsia conorii, Shigella Flexniri 
and Toxoplasma gondii (Jagannath et al., 2007; Birmingham et al., 2006; Nakagawa 
et al., 2004; Rich et al., 2003; Gutierrez et al., 2004; Ogawa et al., 2004). 
 Autophagy is triggered in response to both innate nd adaptive stimuli. 




cytokine input or PRR stimulation can modulate this process. TLR ligands, LPS, 
imiquimiod, and siRNA induce autophagy in macrophages to clear M. tuberculosis 
(Xu et al., 2007; Gutierrez et al., 2004). In the case of adaptive immunity, IFN-γ, and 
CD40 signaling triggers autophagy to sequester the vacuolar pathogens M. 
tuberculosis and T. gondii, respectively (Singh et al., 2006; Andrade et al., 2006). We 
have reported that CD40 stimulation on macrophages signals through its’ adaptor 
protein TNF Receptor Associated Factor 6 (TRAF6) to induce autophagosome 
formation around the parasitophorous vacuole of T. gondii (Andrade et al., 2006). 
Together, autophagy is capable of pathogen degradation induced by several stimuli to 
target a range of pathogens, both free within the cytosol and vacuolar pathogens that 
routinely evade host recognition. I  addition to activation of autophagy, there is alo a 
feedback loop in which autophagy stimulates TLR signaling. For example, autophagy 
delivers viral products of Sendai virus and vesicular stomatis virus to TLR7 in 
endosomes and leads to activation and subsequent type 1 interferon production in 
plasmacytoid DCs (Heung et al., 2007). 
Pathogen Subversion of Autophagy 
Autophagy is considered as innate immune surveillance mechanism 
against intracellular pathogen including viruses. Selective autophagy which 
removes viruses and bacteria is known as Xenophagy. Autophagy can 
suppress replication of certain viruses and also involves in the presentation of 
some viruses to endosomal pattern recognition receptor which ultimately 




viruses also exploit autophagy for their replication and for disease 
progression. Thus, autophagy may function as pro-viral or anti-viral 
mechanism. Several families of DNA and RNA viruses manipulate autophagy 
for their replication and survival. 
 Given the importance of autophagy as a powerful defense mechanism 
against intracellular pathogens, microbial virulence may be partly dependent 
on pathogen antagonism of this pathway. Indeed, there are a few pathogens 
reported to block autophagy induction through expression of specific proteins 
that interfere with Atg proteins and the formation of an isolation membrane. 
Shigella flexniri, an invasive bacteria, prevents Atg5 from targeting the 
Shigella protein VirG by secreting an additional protein, IcsB, which forms a 
complex with VirG to avoid Atg5 binding and autophagosome sequestration 
(Ogawa et al., 2004). Furthermore, Orvedahl et al. found that the 
neurovirulence protein Icp34.5 encoded by herpes simplex virus 1 (HSV-1) is 
able to bind to Beclin 1 and prevent autophagy induction (Orvedahl et al., 
2007). Interestingly, mice that are infected with recombinant HSV-1, defective 
in Icp34.5, are severely deficient in neurovirulence, suggesting that 
autophagy is a potent host defense mechanism in vivo and HSV-1 must 
inhibit autophagy in order to result in a robust infection (Orvedahl et al., 
2007). 
It is possible that pathogens could modulate cell signaling pathways that 
activate or inhibit autophagy. As mentioned previously, Akt is an important signaling 




pathogens utilize host proteins in order to promote survival. Akt is one such protein 
activated by a range of intracellular pathogens including L. monocytogenes, S. 
typhurmium, M. tuberculosis, and T. gondii. Interestingly, all of these pathogens are 
susceptible to autophagic degradation. It is unclear if pathogens are capable of 
modulating autophagy through disruption of host signaling cascades. Identification of 
pathogen subversion of autophagy and further determinants may reveal virulence 
factors and novel therapeutic targets. 
Autophagy and cancer  
Connections between autophagy and cancer are complex and, for the most 
part, still poorly understood. Most of the controversy originates as a result of a 
possible dual role of autophagy in the oncogenic process. In relation to cell death and 
cancer, autophagy is considered as both pro-survival mechanism as well as anti-
survival or pro death mechanism. Autophagy acts as tumor suppressor by removing 
damaged organelles, cell growth control, reducing chromosome instability, 
endogenous antigen presentation, tumor immunity, phsiological cell death, drug and 
radiation induced autophagic cell death. Paradoxically, utophagy is also convicted in 
the tumor progression or survival. Autophagy acts as cytoprotective mechanism that 
helps cancer cells to survive in conditions of low nutrient supply, resist anticancer 
treatment and prevention of apoptosis. So autophagy elps in cancer suppression as 
well as development.Inactivation of autophagy-specific genes, such as beclin 1, has 
been found in different types of tumors and this results in increased tumorigenesis in 




beclin 1 to activate macroautophagy has been shown to effectively inhibit the 
formation of human breast tumors in mouse models, thereby supporting the notion of 
autophagy as a tumor- suppressor mechanism.  
Autophagy also acts as tumor suppressor and decreasd ctivity may 
contribute to development of tumors.  Consistent with this theory, tumor-suppressor 
genes frequently mutated in cancer cells (e.g.,p53, PTEN) are positive regulators of 
macroautophagy whereas, genes that are frequently activated in cancer, such as those 
encoding class I PI3K and AKT, dowregulate macroautphagy (Mizhushima et al., 
2008; Ogier-Denis and Codogno, 2003). However, cancer cells have also been shown 
to utilize autophagy as a pro-survival mechanism in certain conditions such as the 
nutrient-limited environment in the core of solid tumors, or after oncogenic 
treatments aimed at producing damage to rapidly prolife ating cells (i.e., ionizing 
radiation and chemotherapies) (Scarlatti et al., 2008; Paglin et al., 2001).  
 The complexity further increases, when taking into account cell type 
differences in the regulation and use of autophagy, thus suggesting that the role of 
autophagy in cancer biology may likely depend on the type, stage, and treatment 
conditions of the tumor. Pro-survival and pro-death functions of autophagy make 
cancer treatment more complicated. So targeting autophagy for cancer treatment will 
depend on pro or anticancer effects of autophagy in a given tumor condition. To kill a 
tumor cell turning autophagy on or off, either action may be correct. Many currently 
available antitumor agents are potent inducer of autophagy. Ultimately the question to 
whether to turn autophagy on or off may be resolved by information from animal 




Autophagy in Clinical Applications 
Current therapeutic targeting of autophagy in human disease is limited by an 
incomplete understanding of how the process contributes to pathogenesis, the lack of 
specificity of compounds that can influence autophagy, nd the limited availability of 
candidate therapeutics with clinical efficacy (Van-Limbergen et al., 2009; Rubisztein 
et al., 2012; Rubisztein et al., 2007). Pharmacologic enhancement of autophagy (i.e. 
with vitamin D or adenosine 5′-monophosphate–activated protein kinase [AMPK] 
activators) promises to benefit certain diseases (i. ., infectious or neurodegenerative 
diseases) (Yuk et al., 2009; Høyer-Hansen et al., 2010; Yu et al., 2013). Sirolimus, a 
clinically approved immunosuppressive and anticancer drug that inhibits mTOR and 
thereby exerts pleiotropic effects, including the activation of autophagy, has been 
used to enhance autophagy in experimental models (Graziotto et al., 2012). Cytosolic 
or histone deacetylases (i.e., sirtuin-1, HDAC1, HDAC2, and HDAC6) may act as 
regulators of autophagic initiation and of autophagic flux (Moresi et al., 2012). Thus, 
HDAC inhibitors, or inhibitors of lysosomal acidification (e.g., chloroquine and 
hydroxychloroquine), may represent useful pharmacologic strategies for modulating 
autophagy. Current clinical trials are examining the usefulness of autophagy as a 
target in disease. Chloroquine and its derivative, hydroxychloroquine, are being tested 
for enhancement of chemotherapeutic efficacy (e.g., in the Preventing Invasive Breast 
Neoplasia with Chloroquine trial [ClinicalTrials.gov number, NCT01023477] and the 
Phase 1 Trial of MK-2206 and Hydroxychloroquine in Solid Tumors and Prostate 
Cancer [NCT01480154]), including therapies for ductal arcinoma (chloroquine) and 




(hydroxychloroquine). The design of therapeutic agents is complicated by the fact 
that many autophagy proteins, as well as pharmacologic inhibitors (e.g., chloroquine), 
may also affect biologic processes independently of autophagy activation. 
An improved understanding of the mechanism (or mechanisms) by which 
autophagy can prevent pathogenesis may lead to the identification of new targets for 
both diagnostic and therapeutic approaches. Drug screening for agonists or 
antagonists of autophagic activity, including upstream regulators and downstream 
targets of autophagy, may yield additional therapeutic targets. If the advances in 
autophagy continue at an accelerated pace, agents acting on autophagy may 













Vitamin A is a fat-soluble co-factor present in food that is essential for life. It 
plays an important role as a coenzyme in vital processes that the body needs to 
function normally. The structure of Vitamin A makes it good molecule for trapping 
light energy. It is the molecule responsible for transferring light energy into a 
chemical nerve impulse in the eye (Amann, et. al., 2011). It is also important for the 
regulation of biological activities such as embryogenesis, cell growth, differentiation, 
reproduction, apoptosis, and bone formation (Niles, 2000; Sun and Lotan, 2002; 
Mamede, et. al., 2011). 
Physiological metabolites of Vitamin A are collectively known as retinoids. 
Although the most common dietary form of Vitamin A is retinol, there are over 4000 
natural and synthetic molecules that are structurally and/or functionally related to this 
compound. Vitamin A is only obtained through the dit in the form of retinol, retinyl 
esters, or proVitamin A (β-carotene). It is found in foods of plant origin such as sweet 
potatoes and carrots as β-carotene and in animal products such as liver and eggs as 
retinyl esters (Amann, et. al., 2011). 
Retinol is either stored in the liver as retinyl ester  or circulates in the 
bloodstream complexed with plasma retinol-binding protein (RBP) or transthyretin 
(pre-albumin). Plasma membrane receptors for the retinol-binding protein mediate the 
cellular uptake of retinol. After retinol has been taken up by the cell, it becomes 
bound to cellular retinol-binding protein (CRBP). Retinol is first converted to retinal, 
before being metabolized into all-trans retinoic acid (atRA) by a retinal 




becomes bound to cellular retinoic acid-binding protein (CRAPB). The CRABP 
bound retinoic acid is then delivered to the nucleus of the cell by CRABPII, where it 












Fig. 4 Chemical structures of Vitamin A Metabolites:  A) retinol, B) all-trans 




 Retinoic Acid Regulated Gene Expression 
Retinoids signals their cellular effects on biological processes through the 
regulation of gene expression, which is due to the ability of atRA to bind and activate 
specific nuclear receptors. Various scientific studies have highlighted key regulators 
of the retinoid signaling pathway.  There are two distinct sub-families of nuclear 
retinoid receptors. The first are the RARs (retinoic acid receptors) that bind all-trans 
retinoic acid and 9-cis retinoic acid. The RXRs (retinoid X receptors) bind only 9-cis 
retinoic acid. There are three distinct subtypes of RXRs and RARs (α, β and γ), which 
are encoded by different and highly conserved genes. 
The RARs share functional domains common to other members of the steroid 
hormone receptor gene family. The A/B region located in the N-terminal portion 
functions as a ligand-independent transcriptional activ tion domain. The C region 
contains the DNA-binding domain that consists of two zinc-binding, cysteine-rich 
segments. The D domain acts as a hinge, whereas the E s gment acts as a 
dimerization interface for ligand-dependent transcriptional activation. This region is 
highly conserved between all of the RAR subtypes. The C-terminal F region is 
different between the RAR subtypes and at the present time its function is not known. 
However, it is thought that it may bind the coactiva or CBP/p300 (De Lera et. al., 
2007; Niles, 1998). 
 
 
Fig.5 RAR  domain structure and Function: A/B) Ligand -independent 




domain, E)  Ligand binding domain(LBD), dimerization domain and silencing 
domain, F) Domain with Unknown function 
Retinoic acid induces phenotypic changes in target cells by inducing the 
transcriptional activity of the nuclear retinoid receptors. It is the main activator of 
RARs whereas the RXR serves as its common heterodimeric partner. The RXRs have 
the ability to also heterodimerize with other nuclear receptors. These include the 
thyroid hormone receptor (TR), Vitamin D receptor (VDR), PPARs (peroxisome-
proliferator activated receptors), and numerous orphan receptors. The RAR-RXR 
heterodimer binds to a specific sequence located in the promoter region of the DNA 
called a retinoic acid response element (RARE) with a alf site sequence similar to 
AGGTCA. It is a direct repeat (DR) of half sites with a spacer of 2 to 5 nucleotides 
(DR2-DR5). In the absence of ligand, the RAR-RXR dimer is bound to the RARE, 
and held inactive by co-repressors, such as SMRT (silencing mediator of retinoid and 
thyroid signaling) and N-CoR (nuclear receptor co-repressor). These co-repressors 
bind to the non-liganded receptors resulting in suppression of basal transcriptional 
activity. The ability of atRA to bind to the RARs results in destabilization of this 
complex and a conformational change in the receptors that allow for the 
disassociation of co-repressors and binding of co-activ tors, such as SRC-1 (steroid 
receptor co-activator 1) and CBP/p300. Consequently, atRA exerts its effects through 
changing the structure of the receptor, which allows for control of distinct molecular 
events at retinoid regulated promoters (Niles, 1998). 
An important regulatory mechanism that co-activators and co-repressors have 
is that they harbor histone acetylation/deacetylation enzyme activity. Acetylation of 




structure, allowing access of transcription factors t  DNA and therefore, an increase 
in transcriptional activity. Co-activators, such as CBP/p300, contain histone acetyl-
transferase (HAT) activity while co-repressors recruit enzymes that have histone 
deacetylase (HDAC) activity. The level of acetylation is controlled by these two 
opposing families of enzymes, and ultimately, the activity of the RAR/RXR complex. 
Functions of Retinoids  
Retinoids (vitamin A) are crucial for most forms of life. In vertebrates, they 
play vital roles in the developing nervous system and notochord and many other 
embryonic structures, as well as in maintenance of epithelial surfaces, immune 
competence, and reproduction (Fig. 6). The ability of all-trans retinoic acid to 
regulate expression of several hundred genes throug binding to nuclear transcription 
factors is believed to mediate most of these functio s. Retinoids have been called the 
master regulators of differentiation and play critial roles in development (McCaffery 
and Drager, 2000). Retinoic acid is essential for bth embryonic and adult growth. 
Retinoids control patterning of the central nervous sy tem influencing development of 
the hindbrain and spinal cord; the development of the cardiovascular system; 
development of the kidney, eye, ear; and the olfactory pathway, among others 
(Glover, et al., 2006; Hyatt and Dowling, 1997; LaMantia et al, 2000; Maden, 2006; 
Mendelsohn et al, 1999; Mollard et al, 2000; Romand et al, 2006; Vermot et al, 
2003). In short, retinoids control the processes of pr liferation, differentiation and 
apoptosis throughout an organism’s life. Several studies indicate that the effects of 
retinoids on cell proliferation, differentiation and apoptosis are retinoid-specific and 







Fig. 6 Retinoids involvement in various functions: Retinoid have diverse 
physiological functions and very vital for the process of vision, development and 
differentiation. Retinoids induces apoptotic cell death by TRAIL receptors but role of 
retinoids in autophagy is not known. 
 
Retinoids in Cellular Proliferation 
 
Progression through the cell cycle, from the Gap1 (or growth phase 1) to 
mitosis (M), is tightly regulated by the levels and activity of specialized groups of 
proteins known as cyclins, cyclin-dependent kinases (CDK) and cyclin-dependent 
kinase inhibitors (CDKI) (Golias et al, 2004). Retinoids influence each one of these 
groups of proteins. For example, retinoic acid induces growth arrest in myeloid cell 
lines by up-regulation of p21/CIP1 and p27/KIP1 (CDKIs); down-regulation of cyclin 
E and cyclin D1/D3, cyclin A and cyclin B; decreased CDK activity; and de-
phosphorylation of pRb (Dimberg and Oberg, 2003). In EBV-immortalized B 
lymphocytes, ATRA-, 9-cis RA- and 13-cis RA- triggered growth arrest is associated 




CDK2, CDK4 and CDK6; decreased levels of cyclin D3 and cyclin A; as well as 
increased expression of p27/KIP1 (Zancai et al, 1998).Within the sebaceous gland, 
13-cis RA has been shown to decrease proliferation of sebocytes as evidenced by 
decreased 3H-thymidine labeling after 12-weeks of treatment when compared to 
baseline (Landthaler, et al., 1980). No studies to date have examined the nature of this 
decrease in proliferation. 
Retinoids in Cellular Differentiation 
 
Differentiation can be defined as a series of biochemical and structural 
changes by which cells become specialized in form and function. The most studied 
example of retinoids controlling differentiation is the patterning and formation of the 
hindbrain during embryonic development (Glover, t al., 2006). In this case, the 
timing of and the gradient expression of retinoic acid determines the antero-posterior 
as well as the dorso-ventral axes of the hindbrain (Avantaggiato et al, 1996; Glover, 
et al., 2006). Excess retinoic acid in the anterior region results in a “posteriorizing” of 
the hindbrain whereas decreased retinoic acid in the posterior region results in an 
“anteriorizing” of the hindbrain (Glover, et al., 2006; Thompson et al, 1969), which 
upsets the normal developmental patterns leading to deleterious defects. In addition, 
the gradient of retinoic acid expression influences the expression of the Hox genes, 
which are critical in rhombomere segment determinatio  (Simeone et al, 1990; 
Wilkinson et al., 1989; Wood et al, 1994). Furthermo e, the pattern formation of the 
hindbrain is specific to the type of retinoid (i.e. all-trans retinoic acid (ATRA)). 
Exogenous administration of 9-cis RA in zebrafish has a more pronounced effect than 




system example illustrates the fact that the amount f retinoic acid and the specific 
isoform of retinoic acid present can have profound effects on differentiation. 
Retinoids also influence differentiation in skin. The earliest studies noted that 
deficiency of vitamin A in the diet of laboratory animals led to changes in the normal 
epithelium, with specific loss of the mucous secretory epithelium, while replenishing 
the vitamin A restored the normal phenotype (Wolbach nd Howe, 1925). Retinoids 
inhibit the differentiation of keratinocytes as evidenced by decreased keratin 1, 
keratin 10, transglutaminase, loricrin, and filaggrin expression (Fisher and Voorhees, 
1996). De Luca et al. have studied the effects of retinoids in mouse endocervical 
epithelia undergoing squamous metaplasia as a result of retinoid deficiency. Their 
studies show that vitamin A deficiency causes a simple-columnar epithelium to 
gradually become squamous metaplasia and that vitamin A concentration is a factor 
in maintaining a simple or more stratified epithelial morphology (De Luca et al, 
1995). In addition to retinoid effects on epithelium, it can also influence the dermis. 
For example, it modulates the expression of the genes for hyaluronate and collagen, 
two major constituents of the dermis. It increases their expression, synthesis and 
concentration in the skin, helping to reduce wrinkle formation (Sorg et al, 2005). 
Within the sebaceous gland, retinoids inhibit differentiation as determined by 
decreases in sebum secretion with 13-cis RA treatment (Strauss, et al., 1980). 
Retinoids and Immune functions 
Studies over the years have demonstrated the pleiotrop c influence of vitamin 
A on immunological fitness (Hall et al., 2011). Vitamin A elicits a broad array of 




2010; Duester, 2008;Underwood, 2004; Ziouzenkova et l., 2007). Recent evidence 
indicates that loss of RA leads to impaired immunity, whereas excess RA can 
potentially promote inflammatory disorders. Vitamin A's critical contribution to 
immunological health is shown by the fact that its supplementation dramatically curbs 
young-childhood mortality in endemic regions of malnutrition (Rahmathullah et al., 
1990; Sommer, 2008; Sommer et al., 1986). Over the last 20 years it has become 
clear that retinoic acid influences multiple immune c ll lineages and an array of 
immunological functions (Cantorna et al., 1995; Chun et al., 1992). 
In populations where vitamin A availability from food is low, infectious 
diseases can precipitate vitamin A deficiency by decreasing intake, decreasing 
absorption, and increasing excretion. Infectious diseases that induce the acute-phase 
response also impair the assessment of vitamin A status by transiently depressing 
serum retinol concentrations. Vitamin A deficiency impairs innate immunity by 
impeding normal regeneration of mucosal barriers damaged by infection, and by 
diminishing the function of neutrophils, macrophages, and natural killer cells. 
Vitamin A is also required for adaptive immunity and plays a role in the development 
of T both-helper (Th) cells and B-cells. In particular, vitamin A deficiency diminishes 
antibody-mediated responses directed by Th2 cells, although some aspects of Th1-
mediated immunity are also diminished. These changes in mucosal epithelial 
regeneration and immune function presumably account for he increased mortality 
seen in vitamin A-deficient infants, young children, and pregnant women in many 
areas of the world today (Stephensen, 2001). Historically, vitamin A deprivation and 




acid (RA) controls both the homing and differentiation of regulatory T cells (T(reg)) 
(Pino-Lagos et al, 2008). RA also regulate the antibody response in vivo. RA 
regulated factors known to be required for Immunoglobu in class switch 
recombination and modulated the population dynamics of B cells (Chen and Ross, 
2005) 
Retinoids and Apoptosis 
On the basis of morphological characterstics, apoptosis has been defined as 
highly-regulated, well-orchestrated series of events culminating in nuclear 
condensation, DNA fragmentation, membrane-blebbing, cell shrinkage, and 
eventually phagocytosis of the dying cell (Wyllie et al, 1980).  There are two well 
characterized pathways which lead to apoptosis: death receptor (extrinsic) and 
mitochondrial (intrinsic) apoptotic pathways. Death receptors on the cell’s surface 
detect extracellular stimuli and upon binding of their respective ligands, rapidly 
activate an intracellular caspase signaling cascade that results in apoptosis. The 
ligands for death receptors include tumor necrosis factor related apoptosis inducing 
ligand (TRAIL) and Fas ligand (FasL, CD95L) (Slee et al, 1999; Smith et al, 2003; 
Wehrli et al, 2000).The mitochondrial apoptotic pathway is activated by intracellular 
damage sensed by the mitochondria itself resulting in permeability of the outer 
mitochondrial membrane and release of cytochrome c. (Green and Kroemer, 2005; 
Lucken-Ardjomande and Martinou, 2005). These two pathw ys converge with 





It is well established that retinoids induce apoptosis in numerous cell types, 
both normal cells and tumor cell lines. 13-cis RA reduces the survival and genesis of 
murine hippocampal neurons in vivo (Crandall et al, 2004; Sakai et al, 2004). ATRA 
has been shown to induce apoptosis in primary and metastatic melanoma cells as well 
as inducing growth arrest followed by apoptosis in orbital fibroblasts isolated from 
Graves’ disease patients (Pasquali et al, 2003; Zhang and Rosdahl, 2004). In leukemia 
cells, 9-cis RA inhibited cell growth and induced apoptosis to a greater extent than 
13-cis RA or ATRA; however, in adult T cell leukemia cells, all three retinoids were 
equally effective (Fujimura et al, 2003; Koistinen t al, 2002).These studies are only a 
few of many in the literature that demonstrate thate actions of retinoids are unique 
and specific to the model used. Natural and synthetic r inoids induce apoptosis by 
activation of the extrinsic or intrinsic pathways or simultaneous activation of both 
pathways in a retinoid- and cell-type specific manner. The cellular targets of retinoids 
leading to activation of the cell death pathways are just beginning to be revealed. 
 
Retinoids and Cancer 
Role of retinoids in cancer prevention was first suggested in 1925 when 
vitamin A was reported as required for epithelial ce l homeostasis [Wolbach SB, 
Howe PR]. Since then various retinoid compounds have been characterized and used 
as both chemopreventative and chemotherapeutic agents for the treatment of many 
types of cancers. The vitamin A metabolite, retinoic acid (RA), first received 
attention as an interventional therapy upon discovery that it could substitute for more 




promyelocytic leukemia (APL), a malignancy caused by genetic translocations with 
the retinoic acid receptor (RAR), RARα (de Thé and Chen, 2010). Numerous 
investigations of APL have highlighted the ability of RA to promote myeloid cell 
differentiation (Kastner et al., 2001).  
Derivatives of vitamin A, the retinoids, have reported activity in treating 
specific premalignant lesions and reducing incidence of second primary tumors in 
patients with prior head and neck, lung or liver cancers. Studies using Vitamin A 
deficient animals showed that there was a strong conection between deficiency and 
the susceptibility to cancer (Chambon, 1994; Sporn et al., 1976). The addition of 
retinoic acid to the media of various types of cancer cells grown in culture was able to 
significantly reduce proliferation (Niles, 2000; Bushue et al.,2010). Retinoic acid can 
induce differentiation in tumor cells such as neuroblastoma (Sidell, 1982), melanoma 
(Wood et al., 1990; Fligiel et al.,1992; Jacob et al., 1998; Niles, 2003), and 
promyelocytic leukemia (Breitman, et. al, 1980). Retinoids are able to elicit their 
effects on malignant cell growth through the regulation of cell growth, differentiation, 
and apoptosis (Lotan, 1995; Bushue et al., 2010; Mamede et al., 2011). 
There is evidence that demonstrates a connection between cellular 
transformation and altered expression of RARs. It is believed that the RAR-β2 
receptor is critical for mediating the growth inhibitory effects of retinoids and its 
down-regulation is correlated with the loss of atRA’s ability to inhibit cell growth 
(Lotan, 1996; Sun, 2004; Pavan et al., 2006; Bushue et al., 2010). The expression of 
this receptor is down-regulated in head and neck cancer, melanoma, breast, and oral 




to reacquisition of atRA’s ability to inhibit cell growth (Xu, 2007), therefore it has 
been considered as a tumor suppressor gene. The silencing of RAR-β2 expression is 
due to epigenetic changes, mainly DNA methylation (Virmani et al., 2001; Shaw et 
al., 2006). Current research indicates that, while DNA methylation appears to be the 
predominant mechanism for silencing of RAR-β2 expression, there are other 
mechanisms by which this occurs, such as modulating the levels of acetylation of 
histones H3 and H4 (Fan et al., 2010). 
Retinoids are vitamin A derivatives that critically regulate several 
physiological and pathological processes, including immune functions and cancer 
development. Accumulating evidence indicates that retinoids may exert beneficial 
effects in both immune-mediated disorders and tumors. With regard to cancer, 
retinoids directly target neoplastic cells by inducing differentiation, inhibiting cell 
growth or promoting survival. However, the efficacy of these compounds in cancer 
treatment probably resides in their ability to modulate also the function of immune 
effectors. Vitamin A derivatives are currently used in the therapy of acute 
promyelocytic leukemia and of cutaneous T cell lymphomas, but they could be 
effective also on B-cell malignancies. Clinical trials are ongoing to test their efficacy 









Cation-independent Mannose-6-Phosphate receptor (CI-MPR) 
Retinoic acid (RA) exerts diverse biological effects in the control of cell growth 
in embryonic evelopment and oncogenesis (De Luca, 1991; Sporn et al., 1994). 
Several of these specific physiological functions or the non specific side effects of the 
retinoids cannot be attributed to the classical nuclear receptor i.e. RAR and RXR. 
Evidence suggests that other retinoid response pathways that are independent of the 
nuclear receptors may exist (Ahuja et al., 1997; O’Connell et al., 1996; Delia et al., 
1993). It has been shown that the retinoid-induced apoptosis or growth inhibition is 
independent of the action of the nuclear receptors which suggests that other retinoid-
response pathways may exist (Ahuja et al., 1997; Shao et al., 1995; O’Connell et al., 
1996; Sun et al., 1997; Toma et al., 1998; Mologni et al., 1999; Clifford et al., 1999; 
Kim et al., 1995). Thus, despite our knowledge of the nuclear receptors for RA, how 
RA can exert a great diversity of biological effects is still not fully understood. 
Interestingly, photoaffinity labeling studies has shown direct binding of ATRA to 
the cation-independent mannose-6-phosphate/IGFII receptor (CIMPR) with high 
affinity, however, the binding site for ATRA is not known (Kang et al., 1997). 
Photoaffinity labeling studies have demonstrated that the Mannose-6-
Phosphate/Insulin Growth Factor-2 Receptor (M6P/IGF2R) is a novel receptor for 
Retinoic acid (RA) (Kang et al., 1997). RA binds to the M6P/IGF2R with high 
affinity (KD of 2–3 nM). The binding site for RA
 on the receptor protein is distinct 
from the binding sites for M6P and IGF2. Binding of RA enhances binding of the




binding of RA to the M6P/IGF2R seems to facilitate the endocytosis and sorting 
functions of the receptor (Kang et al., 1998). Furthe more, another study showed that 
the interaction of RA with the M6P/IGF2R leads to an intracellular redistribution of 
the receptor and lysosomal enzymes (Kang et al., 1998). These studies suggested that 
RA may act as a functional promoter of the M6P/IGF2R by directly binding to its 
unique site on the receptor. Furthermore, in continuation of these studies, it was also 
demonstrated that M6P/IGF2R mediates the growth inhibitory effects of retinoids 
(Kang et al., 1999). 
 CI-MPR is a ubiquitously and constitutively express d glycoprotein that plays 
fundamental role in endocytosis and degradation of extracellular ligands (IGF-II, 
uPAR), lysosomal enzyme trafficking and regulation f apoptotic and mitogenic 
effects (El-shewy et al., 2009). The primary function of CI-MPR is to sort and 
transport mannose-6-phosphate (M6P) bearing glycoproteins (such as hydrolases) 
from TGN to endosomes/lysosomes. However it is distinct from those for M6P and 
IGF-II on the receptor (El-shewy et al., 2009).  
The cation independent mannose-6-phospahte receptor (CI-MPR) /insulin like 
growth factor 2 receptor (IGF2R) is a multiple ligand-binding cell surface receptor, 
ubiquitously expressed in human tissues. The CI-MPR is a large 300KDa 
glycoprotein which binds Mannose -6-phosphate (M6P), containing ligand and non-
M6P ligands. The human CI-MPR is 2491 amino acid long and includes a N-terminal 
signal sequence of 40 amino acid, an extra cytoplasmic domain consisting of 15 
homologous repeat sequences of 134-167 amino acid (2264 amino acid for the full 




cytoplasmic domain of 164 amino acid which constitute the C-terminal domain. The 
cytoplasmic domain contains various sorting signals as well as various motifs to 
interact with adaptor proteins (Gosh et al., 2003). 
Functions of CI-MPR/IGF2R  
CI-MPR have myriad of important physiological functions. Approximately 90% 
of CIMPR molecules are located in the Golgi and endosomal compartments. 
Receptors (5-10%) are also present on the plasma membrane; these two cellular pools 
cycle continuously internalizing extracellular peptides and participating in Golgi to 
endosome transfer of M6P proteins (principally lysosomal enzymes) ( Kornfeld, 
1992). The major role of the CI-MPR is to facilitate the trafficking of lysosomal 
enzymes between TGN, endosomes and lysosomes. The CI-MPR is also rapidly 
internalized upon binding of other ligands including IGF2, granzyme B, 
UPAR/plasminogen, glycosylated Leukemia inhibitory factor (LIF), Angiogenic 
peptide proliferin, prorenin and Retinoids (Hawkes and Kar, 2004). The regulation 
motif “YSKV”, which binds assembly protein-1 and protein-2 (AP-1 & AP-2) is the 
main mediator of IGF2 R internalization via clatherin-coated vesicles (CCVS) and 
lies in the cytoplasmic tail. 
Accumulating evidence suggests critical role played by CI-MPR n growth and 
differentiation.Binding of IGF-II to the CI-MPR results in the internalization and 
subsequent degradation of the ligand in the lysosome , thereby suppressing 
mitogenesis by reducing IGF-II availability for bindi g to the IGF-I receptor. CI-
MPR binds with the latent transforming growth factor- β (TGF- β), permitting 




(Dennis and Rifkin, 1991).  Retinoic Acid (RA) has been shown to increase 
lysosomal enzyme sorting via CI-MPR and stimulate IGF2R mediated IGF2 
internalization, which contributes to the regulation f cellular proliferation by 
retinoids. 
The CI-MPR gene is regarded as a tumor suppressor gene. The ability of CI-
MPR to modulate local levels of mitogen IGF2 to facilitate actvation of growth 
inhibitor TGF- β1 and to regulate trafficking of lysosomal enzymes indicates that it 
could be a tumor suppressor. Loss of CI-MPR functio is associated with progression 
of tumorigenesis. Frequent loss of heterozygocity (LOH) at the CI-MPR locus has 
been reported in human liver, breast, lungs, ovarian and adrenocortical cancers. CI-
MPR may be involved in the process of cell migration and invasion by IGF2 












Acidification of intracellular organelles 
The luminal pH of endocytic organelles and lysosomes is acidic, and 
acidification  and  its regulation constitute an  important part of endosome maturation 
(Huotari and  Helenius, 2011). Early Endosomes (EE) have a pH in the 6.1–6.8 range, 
Late Endosomes (LE) in the 6.0–4.8 range, and in lysosomes the pH can drop to 
values around 4.5 (Maxfield and Yamashiro, 1987). The low pH not only provides a 
better environment for hydrolytic reactions, but it is also essential for membrane 
trafficking, for the sorting and routing of cargo, f r the inactivation of internalized 
pathogens, etc. The difference in extracellular and EE pH (or between the TGN and 
LEs) provides the asymmetry needed to allow receptors  bind ligands in one 
compartment and release them in the other (Huotari and Helenius, 2011). Thus, the 
progressively decreasing pH in the endocytic pathway can provide incoming cargo a 
‘sense’ as to their location within the pathway. This is most clearly illustrated by 
viruses and bacterial toxins that have a relative sharp pH threshold adjusted so that 
they are specifically activated when they arrive in EEs, in LEs, or in lysosomes 
(Mercer et al., 2010). 
 
Acidification of various organelles requires many proteins, enzymes and proton 
pumps including the vacuolar H+-ATPase. The vacuolar H+-ATPase is an universal 
component of eukaryotic organisms. It is present on membranes of many organelles, 
such as endosomes, lysosomes, phagosomes, the Golgi apparatus and secretory 
granules, where its proton-pumping action creates th  low intravacuolar pH found 




multi-subunit proton pumps. It is composed of a membrane sector and a cytosolic 
catalytic sector. It pumps protons from the cytoplasm to the lumen of the vacuole 
using the energy released by ATP hydrolysis. So, it is part of the cellular machinery 
that regulates the cytosolic pH. This pump is electrogenic, i.e. the movement of a 
proton results in the translocation of net charge that is not directly coupled to the 
transport of another ion to maintain electroneutrality, thereby creating an electrical 
potential difference across the membrane (Finbow and Harrison, 1997). 
Acidification of endosomes 
 
Acidification of endosomal compartments, its regulation and its roles in 
endocytosis have been extensively studied (Mukherjee et al., 1997; Clague, 1998). 
Extensive characterization of endosomal compartment pH using endocytosed 
fluorophores such as fluorescein has been carried out in Chinese Hamster Ovary cells 
(CHO cells) and in other fibroblasts. In CHO cells, sorting endosomes have a pH of 
5.9-6.0, the recycling compartment of 6.4-6.5, whereas late endosomes have a pH 
below 6.0 and lysosomes are even more acidic, with a pH between 5.0 and 
5.5.Endosomal acidity is maintained by an ATP-dependent proton pump. Various 
mechanisms may account for different acidities in different endosomal compartments. 
In some cells, acidification of early endosomes is counteracted by the electrogenic 
Na+/K+ pump. This pump generates an inside positive membrane potential that 
makes it more difficult to pump protons inside the endosome. This pump, which 
recycles back to the plasma membrane from early endosomal compartments, is 
present on early endosomes but not on late endosomes, thus allowing the late 




regulates the pH of endosomes and lysosomes. It has been suggested that changes in 
membrane potential could affect the steady-state pH of an endosome by implying 
changes in the coupling between proton translocation and ATP hydrolysis by the 
vacuolar proton pump as the proton concentration and/or positive charge in the 
compartment builds up. 
 Acidification is an essential property for endocyti  sorting and activity of 
lysosomal enzymes. The acidic environment is used to issociate many ligands, 
including insulin, EGF, LDLfrom their receptors within sorting endosomes. This 
could result from a pH-dependent conformational change in the receptors. Another 
example of pH-dependent conformational change is the release of iron from Tf in the 
sorting endosomes, while apo-Tf remains bound to its receptor in the acidic 
endosomes. Some ligands require a lower pH than that found in the early endosomes 
to be released from their receptors; it is the case for MP ligands that are released from 
the CI-MPR at about pH 5.8, corresponding to the pH found in the late endosomes. 
The low pH of late endosomes and lysosomes also ensur  the optimal environment 
for the activity of lysosomal enzymes that have acidic pH optima. 
In addition, the control of the internal pH of endosomal compartments plays a 
role in membrane traffic. First, agents that neutralize endosomal pH such as 
ammonium chloride or monensin inhibit the transport of the fluid-phase endocytic 
tracer HRP between early and late endosomes (Sullivan et al, 1987; Cupers et al, 
1997). Second, upon inactivation of the vacuolar H+-ATPase by bafilomycin A1, 
trafficking between early and late endosomes continues, but that to lysosomes is 




vacuolar H+-ATPase (van Weert et al, 1995). Endosomal Carrier Vesicle (ECV) 
formation from endosomes is inhibited by bafilomycin treatment, whilst initial 
internalization and recycling are essentially unchaged. The mechanism by which 
internal pH alters these properties remain unclear. It seems that the requirement for an 
acidic endosomal lumen reflects the existence of an allosteric transmembrane pH-
sensor governing the assembly of the budding apparatus at the cytosolic surface of the 
early endosomes. Consistent with this, is the finding that ε-COP associates with 
endosomes in a pH-sensitive manner and is required for an in vitro assay of ECV 
formation. 
 
 Acidification of phagosomes 
 
Very similar to acidification of endosomes, maintenance of phaogosomal pH 
is essential for their function. There are many studies which have focused on 
characterization of phagosomal pH utiliazing various pathogen models such as 
Mycobacterium and Staphylococcus. Characterization of phagosomal pH using 
ingestion of FITC-labelled Staphylococcus aureus has been carried out in 
thioglycolate-elicited murine macrophages. After ingestion, the pH of the phagosomal 
compartment decreased rapidly, reaching a steady stte value of 5.8-6.1 (Lukacs et al, 
1990). 
The vacuolar H+-ATPase plays very critical role in regulating the phagosomal 
pH as they are quintessential for the maintaining the pH like in endosomes. The 
substrate requirement and inhibitory profile of phagosomal acidification suggested 
that proton translocation across the phagosomal membrane was mediated by a 




before phagolysosomal fusion occurs and prior to the appearance of lysosomal 
enzyme activity in the phagosomes (Lukacs et al, 1990; McNeil et al, 1983). It seems, 
however, that the vacuolar H+-ATPase accumulates in the phagosomal membrane as 
it matures within the cell (Caron and Hall, 2001). 
Whereas the vacuolar H+-ATPase appears to be the main determinant of 
phagosomal acidification, there are other proton pum s present in the phagosomes 
which could also play essential role in this process. Fractionation studies have 
revealed the incorporation of Na+/H+ exchanger 1 (NHE1) into the phagosomal 
membranes. NHE1 is the predominant isoform of the NHE in macrophages, which 
are ubiquitous membrane transport proteins that play a major role in the regulation of 
intracellular pH and of cellular volume. NHE catalyzes the exchange of extracellular 
Na+ for intracellular H+, a process. Measurements of pH indicate that NHE1 is 
functional in the phagosomal membrane. NHE could therefore contribute importantly 
to phagosomal acidification. However, it has been shown that it is not the case, and 
this has been supported by the finding that the phagosomes are virtually devoid of 
Na+/K+ ATPases. Considering the latter observation, t is conceivable that mature 
phagosomes attain a much more acidic pH than endosomes due, at least in part, to the 
effective removal of Na+/K+ ATPases (Hackam et al, 1997). In conclusion, NHE, but 
not Na+/K+ ATPases, are present in phagosomes. Althoug  present in the 
phagosomal membrane in a functional state, NHE1 does not contribute to the 





Acidification of the phagosomal compartment is crucial to its microbicidal 
functions. There are various mechanisms by which reduc d pH of phagosomes can 
contribute to pathogen degradation and removal.  The elevated proton concentration 
is directly lethal for certain microorganisms. It also helps in blocking pathogen 
survival by not allowing them to proliferate. Secondly, acidification promotes the 
spontaneous dismutation of superoxide to hydrogen proxide which also acts as 
microbicidal. Also this mechanism is proving to be crucial in eliminating the toxic 
free radicals from the cellular environment. Furthemore, maintaining the reduced pH 
is a prerequisite for phagosome-lysosome fusion and it provides optimal conditions 
for the activity of certain hydrolytic enzymes (Lukacs et al, 1990). 
 
 Acidification of Autophagosome 
 
Process of autophagy in eukaryotes is very complex and, debatably, can be 
divided in to the three parts based on autophagosome structure and function. Recently 
formed double membrane structure is described as autophagosome which does not 
have functional degradative capacity. In the subsequent series of events which are 
collectively termed as autophagosome maturation, autophagosomal pH reduces and 
also autophagosome acquire degradative capacity (Fig.7) In the final step 
autophagosome fuses with either endosomal compartment or lysosomal compartment 
delivering the degradative cargo material enwrapped in the autophagosome (Dunn, 
1990). 
Above described series of events are not well understood and  there are not many 
reports suggesting that autophagosome goes through acidification and maturation 




very few reports suggests that just formed autophagosomes are less acidic and hence 
are immature. As autophagosome gets mature, there is progressive decrease in pH and 
autophagosome gets the capacity to form amphisome or aut lysosome. These fused 
vesicular structures have capacity to degrade engulfed cytoplasmic cargo material. 
Historically, autophagosome biogenesis has been topic of extensive investigation but 
studies on later stages of autophagy including putative autophagosome maturation 
process has not received sufficient attention. Only recently, with the advent of 
molecular characterization of autophagy genes and molecular dissection of various 
stages of autophagy, we have started giving due consideration to autophagosome 








Fig.7 Autophagosome Maturation: Process of Autophagy is initiated by the 
nucleation of an isolation membrane or phagophore. Isolation membrane then 
elongates and closes on itself to form an double membrane vesicle called 
autophagosome. In most cases, once the autophagosome has been formed it receives 
input from the endocytic pathway (early and late endosomes and multivesicular 
bodies-MVB). These steps are collectively termed maturation. The amphisomes that 



































Reagents and Antibodies  
All trans-retinoic acid (ATRA) was obtained from Sigma (no. R2625). 
CD2665, a selective RARβ/γ/α antagonist (no. 3800) and docosahexaenoic acid 
(DCHA), a selective retinoid X receptor (RXR) agonist (no. 3687) were purchased 
from Tocris Biosciences, Bristol, UK. Rapamycin (no. 553210) was procured from 
Calbiochem (La Jolla, CA). Retinoids were dissolved in DMSO at a concentration of 
10mM and were stored under N2 in the dark at −80°C. Stock solutions were diluted 
to the appropriate concentrations with growth medium j st before use. The antibody 
against light chain 3 protein (LC3) (nno. M115-3; clone no. 51-11) was from MBL 
International Corp.; the monoclonal antibodies against CIMPR for use in 
immunofluorescence staining were from Abcam (no. 2733-100, clone 2G-11), and for 
Western blotting, from Biolegend (no. 315902, clone-MEM238); the rabbit 
polyclonal antibody against Atg6/Beclin-1 (BECN1) was from Abgent (no. AP-
1818b). The rabbit anti-mTOR polyclonal antibody was from Sigma (no. T2959). The 
rabbit monoclonal anti-phospho-mTOR (no. 2971), rabbit monoclonal antibody 
against Akt (pan) (no. 4691; clone-C67E7), and anti-phospho-Akt1 (no. 4058; clone-
193H12) were from Cell Signaling Technologies. Anti-GFP rabbit polyclonal 
antibody (no. sc-8334), anti-actin mouse monoclonal antibody (no. sc-8432), goat 
anti-mouse-IgG-HRP (no. sc-8432), and bovine anti-rabbit-IgG-HRP (no. sc-2370) 
were from Santa Cruz Biotechnology. For immunocytochemistry, Alexa Fluor-555 
goat anti-mouse IgG (no. A21422) secondary antibody was from Molecular Probes, 
Eugene, Oregon. LysoSensor Green DND-189 (no.L-7535), a pH indicator probe, 




Cell Lines  
HeLa cells were cultured in Dulbecco's modified Eagle's medium (DMEM) 
supplemented with 10% heat-inactivated fetal bovine serum, 1% nonessential amino 
acids, 10mM sodium pyruvate, 2mM glutamine,50 IU/ml penicillin, and 50µg/ml  
streptomycin, in a humidified 95% air/5% CO2 atmosphere at 37°C. For generation of 
the CFP-LC3 stable cell line, HeLa cells were transfected by a plasmid encoding 
CFP-LC3. 
The transfected cells were initially selected with G418 (Sigma; cat# G8168) at 
500µg/ml   of culture media for 2 weeks. Fluorescent cells were subsequently sorted 
with FACS, and individual clones were isolated by the limited-dilution method. 
Stable clones were maintained in medium supplemented with 300µg/ml of G418. In 
all experiments ATRA was used at 1 µM. All transfections were performed by using 
TransPass HeLa transfection reagent (no.M2556S) from New England Biolabs 
(NEB).  
Fluorescent Expression Plasmid Vectors 
Plasmid encoding CFP-LC3 used in this study was previously generated in 
our laboratory and has been described (Marvakis et al., 2006). mCherry-LC3 was 
prepared by digesting pCFP-LC3 with EcoR1/BamH1 and subcloning of the LC3 
ORF into the EcoR1/BamH1 sites of pmCherry-C1 (Clontech). The pmCherry-GFP-
LC3 construct was a generous gift from Dr. Terje Johansen. Lamp1-mRFP plasmid 




pCerulean-Rab7, and pCerulean-Rab9 constructs used in this study were generated in 
our laboratory and described previously (Marvakis et al., 2006).  
Cloning of CI-MPR  
For generating CI-MPR mGFP and mRFP fusion constructs, cellular mRNA 
was isolated from HeLa cells by using the Trizol method. CI-MPR cDNA was 
prepared by using Protoscript-II RT-PCR kit (no.E6400S) from NEB. Amino acids 
110-2491 from the CI-MPR ORF were directly amplified from the cDNA by using a 
forward primer (ctggaattcaacacaacagtg) containing the only EcoRI site in the 
sequence and a reverse primer (ctgaccggtaaGATgtgtaaaggtcctcgtc) which contains a 
unique AgeI site. The three capital letters indicate in reverse orientation the last amino 
acid of the CI-MPR ORF. The PCR product was digested with EcoRI/AgeI and 
cloned in frame at the EcoRI/AgeI sites of plasmid mGFP-N1. The ORF encoding the 
first 109 amino acids and also a Kozac sequence and XhoI/EcoRI flanking sites were 
artificially synthesized (Genescript Inc.) and subcloned in the Xho/EcoRI sites of the 
mGFP-N1 vector containing amino acids 110-2491, thus creating CI-MPR-mGFP. 
An Xho/AgeI site from the last vector was also subcloned in the XhoI/AgeI sites of 
plasmid mRFP-N1 to create CI-MPR-mRFP. These construct  therefore express the 
full ORF of CI-MPR, including the signal peptide, and the fluorescent tag is placed in 
the c-terminus of CI-MPR. The c-terminus of CI-MPR is exposed toward the cytosol, 






siRNA/ RNA interference Oligomer Sequence  
HeLa cells were transfected with annealed double-stranded Silencer select 
validated siRNA against CI-MPR from applied biosystem (siRNA ID no. s7217) as 
designated in the experiments by using the manufacturer's suggested protocol. The 
sequence for the siRNA used is CUACCUGUAUGAGAUCCAAtt (sense) and 
UUGGAUCUCAUACAGGUAGtt (antisense). Chemical treatments in transfected 
cells were initiated 8 h after transfection, and cells were analyzed 48 h after 
transfection. 
General Methods  
To obtain total cell lysates after a designated incubation period with various 
treatments, cells were washed twice with ice-cold PBS, lysed in RIPA buffer 
[150 mM NaCl, 50 mM Tris-HCl (pH 8.0), 0.1% Nonidet P-40, 0.5% deoxycholate, 
0.1% sodium dodecylsulfate (SDS), protease inhibitor c cktail (Sigma), and 
phosphatase inhibitor cocktail], and clarified by high-speed centrifugation. For 
Western blot analysis, equal amounts of total protein were separated by SDS-PAGE 
and then transferred to nitrocellulose membranes. Membranes were blocked with 
blocking buffer (TBST-1% casein) for 1 h, probed with primary antibodies for 2 h and 
then incubated with the HRP-conjugated secondary antibody for 1 h. Antibody 
binding was detected by enhanced chemiluminescence (Am rsham). Density for each 
band was analyzed by using a densitometer. Equal protein loading was confirmed by 
probing against β-actin. Values obtained for phosphorylated mTOR and 




respectively. For immunofluorescence, cells were grown on chambered coverslips. At 
the end of the experimental treatment, the cells were fixed with 4% paraformaldehyde 
in 0.1 M phosphate buffer (15 min), washed with wash buffer (PBS/0.1% saponin), 
blocked for 1 h with blocking buffer (PBS/1% BSA/0.1% saponin), and sequentially 
incubated with the primary and secondary antibodies in blocking buffer. After the 
final wash, the chambers were filled with mounting media (80% glycerol, 100 mM 
Tris, pH 8.0) containing antifade (DABCO) and analyzed by confocal microscopy. 
 Confocal Microscopy  
For colocalization studies, cells were seeded overnight in Lab-Tek chambers 
(Nalgene Nunc, Rochester, NY) and co-transfected with the plasmids of interest or 
siRNA targeting CIMPR gene, by using TransPass HeLa transfection reagent. 
Confocal microscope images of cells 24 to 48 h after transfection were captured on a 
Zeiss LSM 510 confocal microscope or by using the 458-nm line of an Ar laser with a 
465–505 emission filter for CFP, the 488-nm line of an Ar laser with a 505–550 
emission filter (GFP), a 543-nm HeNe laser line with a 560–615 emission filter line 
for mCherry/mRFP. Images were captured with a Plan-Apochromat 1.4 NA 63 × oil-
immersion objective. Cells expressing both proteins were selected for z-sectioning. Z 
stacks were taken by using a pinhole of 0.5 Airy units for both channels. Images were 







Results are presented as the mean ± SEM from three independent experiments. 
Two group comparisons were performed by using Student's t test. Multiple group 





























Nutrient availability is one of the best-characteriz d factors involved in 
regulation of autophagy. The great sensitivity of the autophagic response to the 
nutritional state implies that certain macro- or micronutrients regulate this response. 
In general, macronutrient (proteins, carbohydrates, lipids) availability suppresses 
autophagy. With the exception of certain vitamins, the effect of various dietary 
micronutrients on autophagy has not been examined. Most vitamins studied have 
been found to stimulate autophagy. Vitamin A metabolite, Retinoic acid (ATRA), has 
diverse biologic effects in the control of cell growth and differentiation. Despite our 
knowledge of the diverse effects of retinoic acid on several cellular functions, its 
effect on autophagy has not been studied. In our present research, we proposed to 
study the possible functional relationship of vitamin A with autophagy pathway. In 
order to investigate the putative role of ATRA on autophagy, we analyzed the effects 
of ATRA treatment on the expression of autophagosome marker LC3 fused with 
various flurorescent marker genes (CFP, mCherry) in dividing HeLa cells. Autophagy 
is very quick process and autophagosome has a half life of 10 min. To investigate the 
autophagosome spatially and temporally, we generated H La stable cell line 
expressing CFP-LC3. Autophagosome biogenesis was studied by following the LC3 
expression pattern after ATRA treatment. Autophagosome maturation process was 
studied by LC3 sub cellular localization by confocal microscopy following treatment 





ATRA Reduces the Number of Non-acidified Autophagosomes 
To investigate the role of retinoic acid and analogues in autophagy, we 
initially generated a stable HeLa cell line expressing LC3 fused to the carboxy 
terminus of CFP (LC3-CFP). Attempts to generate LC3- EYFP, LC3- GFP, or LC3-
mCherry stable cell lines were unsuccessful, presumably because of the toxic effects 
of these fluorescent proteins when expressed over th  long term as LC3 fusion 
proteins. The stable cell line is expressing CFP-LC3-I, which exhibits diffused 
cytosolic and nuclear distribution. Cleavage of a small carboxy-terminus portion from 
LC3-I and lipid conjugation generates LC3-II, a protein that has been shown 
specifically to associate with double membranes of maturating autophagosomes 
(AUTs) and decorates both the cytosolic and luminal sides of the organelle (Bampton 
et al., 2005; Eskelinen, 2005; Kabeya et al.,2000; Marvakis et al., 2006), thus 
appearing as distinct punctuate structures. The ratio of LC3-I to LC3-II correlates 
very well with the total number of AUTs present at any time, and for that reason has 
been extensively used as measurement for steady-state levels of maturing AUTs. The 
ratio of LC3-I/LC3-II is not informative on the maturation level of AUTs or the 
degree of their acidification. 
Treatment of HeLa-LC3 cells with 1 µM ATRA for 48 h resulted in substantial 
reduction of CFP-LC3-positive structures, whereas treatment with 0.5 µM of 
rapamycin (a known activator of autophagy) induced a robust increase of CFP-LC3 






FIG. 8 Effect of ATRA and Rapamycin on abundance of AUTs in Stable HeLa 
Cells: CFP-LC3 stably transfected HeLa cells (CFP-LC3-S) were treated with ATRA 
(1.0 µM) or Rapamycin (0.5 µM) for 48 hrs. The experim nt was repeated three 
times. 
To confirm that this observation is not limited to the stable cell line, we 
treated CFP-LC3 transiently transfected HeLa cells and obtain similar results (Fig. 9).  
 
Fig. 9 Effect of ATRA and Rapamycin on abundance of AUTs in transiently 
transfected HeLa Cells: CFP-LC3 transiently transfected HeLa cells (CFP-LC3-T) 





Fig. 10 Quantification of the number of AUTs per HeLa cell: CFP-LC3-S (stable 
cell line), mCherry-LC3-T (transiently transfected) and CFP-LC3-T (transiently 
transfected) cells treated with ATRA or Rapamycin (Rapa) or CNT (Left untreated). 
For quantification, cells were optically sliced on a confocal microscope and then 
maximal-intensity z-projections were generated for each cell to visualize all AUTs. 
LSM images were exported as TIFF files, and the number of AUTs was quantified by 
using Image J. The data are presented as the average number of AUTs in each group. 
Treatments with different superscripts are statistically different (b>a, b>a1, a>a1>a2, 
b1>a1). Data shown are the mean ± SEM from three ind pendent experiments. 
In both cases, CFP-LC3 stably and transiently transfected HeLa cells, ATRA 
reduced CFP-LC3 structures by almost 50% (Fig. 10) but did not affect the ratio of 
CFP-LC3-I to CFP-LC3-II (Fig. 11). Rapamycin treatment though resulted in a 
substantial reduction of the CFP-LC3-I to CFP-LC3-II ratio.  
Surprisingly, ATRA treatment did not affect the abundance of mCherry-LC3 
positive AUTs in transiently transfected HeLa cells (Fig. 12). Given that CFP is very 




suggested that ATRA either increases acidification of autophagosomes (amphisomes) 
or increase the autophagosome–lysosome fusion rate. 
 
Fig. 11 Western Blott analysis of whole cell lysate collected from CFP-LC3-S 
HeLa cells: Parallel cultures of CFP-LC3-S cells were collected after 48 hrs of 
treatment, and total cell lysates were separated by SDS-PAGE, and subjected to 
immunoblotting with anti-LC3 and anti-β Actin. The results are representative of 
three independent experiments. The intensity of the bands was quantified by Image J, 
and the ratio of LC3-I to LC3-II was calculated. Bars represent the mean ± SEM from 
three independent experiments. The intensity of the bands was quantified by Image J, 
and the ratio of LC3-I to LC3-II was calculated. Bars represent the mean ± SEM from 







Fig. 12 Confocal image analyses of mCherry-LC3-T (transiently transftected) 
HeLa cells: mCherry-LC3 transiently transfected HeLa cells were treated with 
ATRA (1 µM) or Rapa (0.5 µM) for 48 h. 
 
ATRA does not affect the levels of upstream regulators of autophagy  
Induction of AUT biogenesis requires two complexes. The first one, that 
initiates vesicle formation, contains the class III PI3K (Vps34), Beclin-1/Atg6, Atg14, 
and Vps15/p150 and is highly controlled by Beclin-1. Beclin-1, the mammalian 
homologue of ATG6, was the first protein shown to be indispensible for autophagy in 
mammals (Bonifacino and Rojas, 2006; Kihara et al., 2001; Liang et al., 1999). The 
second complex, responsible for the vesicle nucleation, contains Atg1/ULK1, 
mAtg13, mAtg13-associated proteins FIP200, and Atg101 in mammalian cells, the 
association of which is controlled by mTOR (Mizhushima, 2010). Autophagy is 
negatively regulated by the serine/threonine kinase mTOR (mammalian target of 
rapamycin) (Marvakis et al., 2008; Wullschleger et al., 2006). Phosphorylated mTOR 




autophagy (Schmelzle and Hall, 2000). In addition, activated mTOR induces 
hyperphosphorylation of Atg13, which reduces its binding affinity to other Atg 
interacting proteins, thereby inhibiting autophagy (Kamada et al., 2000). One well-
characterized pathway for mTOR activation involves Akt1 activation. Akt1 
phosphorylates and inhibits the tuberous sclerosis complex 2 (TSC2) (Potter et al., 
2002). TSC2 negatively regulates mTOR by acting as a GTPase-activating protein 
(GAP) for the small GTPase Rheb, which binds and activ tes mTOR (Long et al., 
2005). Therefore, elevated levels of phosphorylated Akt1 (pAkt1) promote conditions 
that inhibit autophagy. 
To investigate whether ATRA affects the levels of AUTs by inhibiting 
induction of autophagosome formation, we examined th  levels of Beclin-1, pmTOR, 
and pAkt1 in HeLa cells treated for 12, 24, and 48 h. Our results indicate that ATRA 
did not affect the total levels of Beclin-1, Akt1, Akt2, Akt3, and mTOR, and neither 
the levels of pmTOR and pAkt1 (Fig. 13). These data suggest that ATRA does not 





Fig. 13 Protein Expression Analysis of critical regulators of autophagy by 
Western Blot: HeLa cells were treated with ATRA (1mM) for the indicated time 
points. At the end of the incubation period, total cell lysates were prepared, and equal 
amounts of proteins were separated on SDS-PAGE. Levels of Beclin-1,mTOR, 
phospho-mTOR, pan (Total)Akt, and phospho-Akt1 were evaluated with 
immunoblotting. Phosphorylated-mTOR levels were asses ed by using a phospho-
mTOR antibody specific for phosphorylation on Ser2448, and phosphorylated-Akt1 
levels were assessed by using a phospho-Akt1 antibody specific for phosphorylation 









Turnover of most long-lived proteins, macromolecules, biologic membranes, 
and whole organelles, including mitochondria, ribosomes, endoplasmic reticulum, 
and peroxisomes, is mediated by autophagy. A basal form of autophagy is essential 
for maintenance of cellular homeostasis, and an inducible form becomes activated 
under stress conditions (nutrient deprivation, infections, and toxins). The overall 
process of autophagy can be generally divided into three parts; induction of the 
autophagosomal membranes, functional and structural autophagosome maturation, 
and fusion with lysosomes. Starvation and nutrient r gulation of autophagy is well 
documented. There have been many reports of studying the effects of 
macromolecules on autophagy. There are very few reports which describe autophagy 
in context of micronutrients regulation.  In the efforts to study the effect of Vitamin A 
on autophagy, our initial experiments suggested that retinoic acids are not involved in 
autophagosome biogenesis, but may play a crucial role in autophagosome 
acidification and maturation. Treatment of ATRA to stable transfected and transiently 
transfected HeLa cells showed that CFP-LC3 positive structures were reduced. 
Contradictory to the previous confocal experiments, we were not able to see any 
difference in the expression level of LC-II at various time points in the HeLa cells. As 
it is well documented that CFP loses its fluorescence i  the  more acidic  environment 
( late autophagosome or amphisomes or autolysosomes), w  speculated that we were 
not able to observe the complete set of profile of autophagosomes (non acidified and 
acidified)  in the CFP-LC3 HeLa cells in the confocal experiments. To observe the 




change the fluorophore to mCherry. mCherry has pKa value < 4.5 and hence tolerates 
acidic environment very well. In the next experiment ATRA treatment to mCherry-
LC3 HeLa cells, we did not observe the reduction in the number of autophagosome 
what we had earlier observed in the CFP-LC3 HeLa cells. This last piece of data was 
consistent with the expression profile of LC3-II observed in the western blot 
experiments.  Further, treatment of ATRA to HeLa cells does not change the 
expression level of key critical upstream modulator of autophagosome biogenesis 
including mTOR, AKT and beclin-1. These initial data indicated that ATRA might be 
involved in the later of autophagy i.e. autophagosome maturation and 
autophagosome-lysosome fusion. In the quest to look  in to the later maturation event 
during the process of  autophagy, in the next experiment we transfected the HeLa 
cells with pH sensitive reporter plasmid mCherry-GFP-LC3. Observation under 
confocal microscope revealed reduction in the number of yellow dots( immature non 
acidified autophagosome) and more number of the red doted ( mature acidified 
autophagosome) structures. pH sensitive reporter plasmid transfection experiments 
provided definitive evidence of involvement of ATRA on autophagosome maturation. 
The mechanism of autophagosome maturation by ATRA and receptor involved in the 
























The ATRA has diverse physiological functions in the various cell types. 
ATRA carried out these functions by regulating the expression of genes through two 
families of nuclear receptors, the RA receptors (RARs) and the retinoid X receptors 
(RXRs). There are many functions of ATRA which cannot be attributed to above 
mentioned nuclear receptor. Retinoids are also frequently used pharmaceuticals. Key 
drawbacks for using these compounds are there non-specific functions and 
undesirable side effects. In addition to the effects of retinoic acid through RARs and 
RXRs, there are evidences which suggest that other retinoid response pathways that 
are independent of the nuclear receptors may exist (Kang et al., 1997; Kang et al., 
1998). Interestingly, previous studies have shown direct binding of RA to the cation-
independent mannose-6-phosphate/IGFII receptor (CIMPR) (Kang et al., 1997).  
In our initial studies data suggested that ATRA treatment to HeLa cells doen 
not affect autophagosome biogenesis. Instead, treatment of HeLa cells reduces the 
number of non-acidified or immature autophagosomes. These observations lead us to 
hypothesize that ATRA treatment might induce the autophagosome maturation or 
later stages of autophagy. To further understand the underlying mechanism of 
autophagosome maturation by ATRA we studied involvement of nuclear receptor 
(RAR and RXR) by using receptor specific agonist and tagonist. We analysed the 
expression and subcellular localization of LC3 in presence of specific agonist to RXR 
receptor and specific antagonist to RAR receptor after treartment of HeLa cells with 




transfecting GFP-CI-MPR and mRFP-CI-MPR in HeLa cells and by employing 
siRNA against CI-MPR.  
 
Role of Nuclear Receptor in AUT maturation By ATRA:  
To investigate whether the effect of ATRA on AUT matur tion is mediated by 
the classic retinoid acid receptors, we perform studies in the presence of receptor-
specific antagonists and agonists. Two distinct classes of nuclear retinoid receptors 
are termed RARs and RXRs, each of which has three distinct subtypes, α, β, and γ. 
The RARs bind ATRA and 9-cis-RA with high affinity, whereas the RXRs bind 9-
cis-RA selectively (Chambon, 1996). At high doses, though (>10 µM), ATRA can 
slightly transactivate RXRs. 
Treatment of CFP-LC3 stably transfected HeLa cells with CD2665 (10 µM) did not 
block the effect of ATRA (1 µM) in reducing the number of CFP-LC3 structure (Fig. 
14), and treatment with CD2665 alone had no effect. CD2665 is a selective RARα/β/γ 
antagonist, with KD values of 0.1, 0.3, and 1 µM for RARγ, RARβ, and RARα, 
respectively (Kim et al., 2000). Actually, the effect of ATRA in reducing the number 
of CFP-LC3-positive structures was even more pronounced in the presence of 
CD2665. Binding of CD2665 to RARs could increase th bioavailability and binding 
of ATRA to another target. Although the effect of ATRA is not expected to be 
mediated by the RXRs, we subjected CFP-LC3 HeLa cells to treatment with DCHA, 




effect. These results strongly suggest that the effct of ATRA is not mediated by the 
classic RARs and RXRs receptors. 
 
Fig. 14 Role of  Nuclear Receptors ( RAR and RXR) in AUT maturation by 
ATRA: The effect of ATRA on AUT maturation is not mediated by the RARα/β/γ 




and treated with 1 mM ATRA, 10 mM CD2665,10 mM DCHA, or 1 mM ATRAþ10 
mM CD2665 in combination. The number of AUTs per cell in each group was 
measured as described earlier. Data shown are the mean ± SEM from three 
independent experiments. 
 
mCherry-GFP-LC3 pH-sensitive reporter Assay 
CFP-, EYFP- and GFP-LC3 are being widely used as markers of maturing 
AUTs. However, these fluorescent proteins are acid labile with a pKa of 6.0 (Shaner 
et al., 2005), making it impossible to monitor AUTs after they become acidified 
(amphisomes) or fused with lysosomes. The luminal pH of late endosomes have a pH 
of about 5.5, and lysosomes have a pH of about 4.7 (Zen et al., 1992). Fusion of the 
monomeric red fluorescent protein mCherry to LC3 alleviates some of these 
problems. The pKa of mCherry is < 4.5, making the protein very acid stable. As we 
showed earlier in this study, the number of mCherry-LC3–positive AUTs is much 
higher than that of CFP-LC3–positive AUTs. Simultaneously to detect both 
nonacidified and acidified AUTs, a mCherry-GFP double-tagged LC3 strategy 
recently was devised (Pankiv et al., 2007). Expression of mCherry-GFP-LC3 results 
in yellow-punctuated structures, which are nonacidifie  AUTs, and red structures, 
which are either amphisomes or autophagolysosomes. In the present study, treatment 
of mCherry-GFP-LC3–transfected HeLa cells resulted in substantial shift of the 
number of yellow-punctuated AUTs in favor of red-labeled AUTs (Fig. 15). After 48 
h of ATRA treatment, almost half of the AUTs displayed red fluorescence only, thus 
confirming our earlier hypothesis that ATRA promotes acidification of maturing 





Fig.15 pH-sensitive reporter Assay: ATRA treatment induces acidification of 
AUTs, as evaluated by using the pH-sensitive reportr GFP-mCherry-LC3. HeLa 
cells were transfected with GFP-LC3-mCherry, and either left untreated or treated 




treatments, cells were prepared for live imaging by using confocal microscopy. The 
number of yellow and red punctuate structures was determined as described earlier. 
The data are presented as percentage of yellow puncta in ontrol cells or cells treated 
with ATRA for the indicated time points. Data shown are the mean±SEM from three 
independent experiments. 
 
Role of CI-MPR in AUT Acidification/ Maturation by ATRA  
As we showed, the effect of ATRA in promoting acidification of AUTs is not 
mediated by the classic RAR and RXR receptors. Earlier studies identified CI-MPR 
as a target for retinoic acid, and showed that retinoic acid can induce translocation of 
the receptor from perinuclear compartments to uncharacterized vesicular structures. 
The best-described function of CI-MPR is to transport mannose-6-phosphate (M6P)-
bearing glycoproteins from TGN to endosomal/prelysosomal compartments. The CI-
MPR is one of two transmembrane proteins that bind M6P tags on acid hydrolase 
precursors in the TGN that are destined for transport to the lysosome. The other 
protein is the cation-dependent mannose-6-phosphate rec ptor (CD-MPR). Newly 
synthesized lysosomal enzymes are posttranslationally modified to contain M6P 
residues on their N-linked oligosaccharides. The M6P residues enable enzymes to 
bind to CIMPR (and CD-MPR) receptors in the TGN. The ligands bind in one of the 
repeats of the large luminal domain. The receptor/ligand complexes cluster into 
clathrin-coated transport vesicles and travel to acidic prelysosomal compartments 
where the low pH causes dissociation of the receptor–ligand complex. The free M6P 
receptors can travel to the plasma membrane or back to the TGN to reinitiate another 




To determine whether RA induces translocation of the CI-MPR in maturing 
autophagosomes, we prepared mGFP- and mRFP-tagged CI-MPR constructs. The 
fluorescent tag was inserted in the carboxy terminus of CI-MPR, which is the 
cytoplasmic domain of the protein, to ensure that acidified organelles will not quench 
the fluorescent signal. We initially transfected the CFP-LC3 stable HeLa cell line 
with CI-MPR-mRFP and examined whether it colocalizes with AUTs in ATRA-
treated (Fig.16b) or -untreated cells (Fig. 16a). CI-MPR-mRFP was localized mostly 
in perinuclear compartments (presumably TGN), some vesicular compartments, and 
plasma membrane. Treatment with ATRA induced a significa t redistribution of CI-
MPR-mRFP to peripheral vesicular compartments, but those were not CFP-LC3–





Fig.16 Colocalization study of CFP-LC3 and CIMPR-mRFP in HeLa Cells: CFP-
LC3 stably transfected HeLa cells, treated with ATR (16b) or untreated (16a), were 
transfected with CIMPR-mRFP; 48 h after transfection, live cell imaging was 
performed with confocal microscopy.  
We also co-transfected ATRA treated and untreated HLa cells with mCherry-
LC3 and CI-MPR-GFP. Even in the absence of ATRA, wenoticed some co-
localization of CI-MPR-GFP with mCherry-LC3–labeled AUTs (Fig. 17a). In 
ATRA-treated cells, significant translocation of CI-MPR-GFP in mCherry-LC3–
labeled AUTs was noticed (Fig. 17b). These data show that retinoic acid induces 
redistribution of CI-MPR in acidified AUTs or autophagolysosomes. 
 
Fig.17 Colocalization study of mCherry-LC3 and CIMPR-mGFP in HeLa cells: 
ATRA treatment induces redistribution of CIMPR from TGN to acidified LC3-




(17a), were co-transfected with mCherry-LC3 and CIMPR-mGFP and subjected to 
confocal microscopy. The images are Z-sections and obtained as described earlier. 
 
In the previous experiments, we showed that ATRA induces the translocation 
of CIMPR in an acidic compartment that is also positive for LC3. This compartment 
can be either an amphisome or an autophagolysosome. Autophagolysosomes are also 
positive for LAMP-1, a lysosomal marker protein. Transfection of ATRA-treated 
HeLa cells with CIMPR-GFP and LAMP-1-RFP and confocal microscopy indicated 
that CIMPR is not recruited in LAMP-1 positive struct res (Fig. 18). This result 
suggests that retinoic acid induces redistribution of CIMPR in amphisomes (acidified 





Fig. 18 Colocalization study of CIMPR-mGFP and LAMP1-mRFP in HeLa 
cells: HeLa cells were co-transfected with CIMPR-mGFP and LAMP1-mRFP and 
either treated with 1 mM ATRA or left untreated. At 48 h later, cells were analyzed 
by using confocal microscopy and Z-sectioning. This images shows that ATRA does 





Role of endogenous CI-MPR in AUT Acidification  
Our studies suggest that CI-MPR may play a critical role in mediating the 
effects of retinoic acid on AUT maturation. We next asked whether downregulation 
of the endogenous levels of CI-MPR could affect autophagy. We used a company-
validated siRNA against CI-MPR in the CFP-LC3 stable cell line and were able to 
document a dose-dependent downregulation of endogenous CI-MPR protein levels 
(Fig. 19).  
 
Fig. 19 Western Blot analysis of expression of CI-MPR in HeLa Cells Afetr 
siRNA-mediated knockdown of CI-MPR: HeLa cells were cultured on six-well 
plates and transfected with increasing concentrations (0, 2.5, 5.0, and 10 nM) siRNA 
against CI-MPR. Cells were lysed 48 h after transfection, and equal amounts of 
whole-cell lysates were separated with SDS-PAGE. CI-MPR levels were measured 
with immunoblotting by using a monoclonal anti-CIMPR antibody (clone MEM-




Transfection of CFP-LC3 cells with 10 nM (final concentration) siRNA 
resulted in a remarkable decrease in the ratio of CFP-LC3-I to CFP-LC3-II (Fig. 20).  
 
Fig. 20 Western blot analysis of LC3 expression after CI-MPR knockdown in 
HeLa cells: CFP-LC3 stably transfected, grown on six-well plates, were transfected 
either with 10 nM siRNA against CI-MPR or mock transfected by using a scrambled 
siRNA and treated with 1 mM ATRA or left untreated. 48 h after transfection total 
cell lysates were obtained and subjected to Western blot analysis by using an anti-
LC3 antibody. 
Visualization of the CI-MPR knockdown HeLa cells under confocal 
microscope also showed a large accumulation of LC3-CFP–positive structures. The 
siRNA-CI-MPR mediated increase of AUTs could not be reversed by ATRA, further 
suggesting that the effect of retinoic acids on AUTs is mediated primarily by CI-
MPR. Immunocytochemistry for endogenous CI-MPR in siRNA-transfected CFP-




cells. Remarkably, the few cells found in which silencing of CI-MPR was not 
effective had normal levels of AUTs (Fig. 21).  
 
Fig. 21 siRNA-mediated knockdown of CI-MPR in HeLa cells: CFP-LC3 cells 
grown on chambered coverslips were transfected with10 nM siRNA against CI-
MPR. At 48 h after transfection; the cells were fixed and processed for 
immunofluorescence staining by using an anti-CI-MPR monoclonal antibody (clone 
2G-11) and Alexa Fluor-555 goat anti-mouse fluorescent secondary antibody, and 
examined with confocal microscopy. 
Transfection of HeLa cells with siRNA against CI-MPR and the pH-sensitive 
reporter mCherry-GFP-LC3 indicated that accumulated AUTs were nonacidified 






Fig. 22 CI-MPR knockdown in HeLa cells transfected with mCherry-GFP-LC3 
pH-sensitive reporter plasmid: HeLa cells grown on chambers were treated with 
ATRA or left untreated and co-transfected with GFP-mCherry-LC3 and siRNA 
against CI-MPR. 
Treatment with ATRA resulted in a slightly decreased ratio of yellow-to-red 
punctuates (Fig. 23), presumably because of incomplete CI-MPR silencing i  a 
portion of cells. This last piece of data suggests that CI-MPR may be involved in 
AUT acidification, and that maturation is a prerequisite for physiologic turnover of 






Fig.23 Quantification of Autophagosome in CI-MPR knockdown HeLa cells: The 
number of yellow and red punctate structures was estimated by using confocal 
microscopy, as described previously. The total number of AUTs and the percentage 
of yellow puncta in each treatment group were analyzed separately. Treatments with 
different superscripts are statistically different. Data shown are the mean ± SEM from 
three independent experiments. 
 
 
Effect of siRNA-mediated knockdown of endogenous CI-MPR on 
Endosomes and Lysosomes  
To determine whether downregulation of CIMPR affects the abundance of 
endosomes or lysosomes or both, we co-transfected HeLa cells with siRNA against 
CIMPR and one of either cerulean-Rab5, cerulean-Rab7, cerulean-Rab9, or Lamp1-
RFP. The cells transfected with Lamp1 were also stained with LysoSensor Green. We 
did not observe any effect on abundance of Rab5- and Rab7-positive endosomes. 
However, knockdown of CIMPR resulted in increased numbers of Rab9-positive 





Fig. 24 Effect of siRNA-mediated knockdown of CI-MPR on Rab9-positive 
endosomes in HeLa cells: HeLa cells grown on chambers were co-transfected with
Rab9-Cerulean and siRNA against CI-MPR or a scrambled siRNA. At 48 h after 
transfection, the number of Rab9-positive structures was estimated by using the 





Knockdown of CI-MPR also did not affect lysosome abundance, but reduced 
the number of Lamp1-positive structures that were also labeled with LysoSensor 
Green, indicating reduced lysosomal acidification (Fig. 25). It should be noted that 
LysoSensor Green stains other acidified structures in addition to lysosomes, and that, 
in addition to CI-MPR, the cation-dependent mannose-phosphate receptor (CD-MPR) 
is also involved in acidification of late endosomes. The contribution of each receptor 
in different compartments is unknown.  
 
Fig.25 Effect of siRNA-mediated knockdown of CI-MPR on Lysosomes in HeLa 
cells: HeLa cells were cotransfected with Lamp1-RFP and siRNA against CI-MPR or 
a scrambled siRNA. At 48 h after transfection, the cells were incubated for 1 h with 2 
mM LysoSensor Green, washed several times with warm medium, and visualized 





Our data clearly indicate that CI-MPR is involved in acidification of AUTs 
and at least partially in the acidification of lysosomes. Accumulation of Rab9-positive 
structure in cells with reduced CI-MPR may suggest tha AUTs fuse with a subset of 
Rab9 endosomes, and may be dependent on this process for their acidification. 
However, Rab9-positive endosomes fuse also with lysosomes, and we have not 
observed significant co-localization of AUTs and Rab9-positive endosomes 
(Marvakis et al., 2008). 
It could be that accumulation of Rab9-positive endosomes is due to their 
reduced fusion with lysosomes. Lysosomes do not carry CI-MPR, and their 
acidification depends primarily on their fusion with late endosomes. However, we 
found that acidified AUTs carry their own CI-MPR, and direct acidification of AUTs 











The initial set of experiments revealed that ATRA induces autophagosome 
maturation. Physiological functions of ATRA in the c lls are attributed to nuclear 
receptors RAR and RXRs, specifically to RARs. To look in to the possible 
involvement of nuclear receptor in the physiological outcome of ATRA treatment to 
HeLa cells in the previous experiments, we used specific antagonist to RXRs and 
agonist to RAR. In the series of experiments with antagonist and agonist treatment to 
HeLa cells, we did not observed any difference in the autophagosome biogenesis and 
maturation. After these experiments we conclude that nuclear receptors are not 
involved in the autophagosome maturation in the HeLa cells.  
There are reports that document the presence of non nuclear receptors for the 
ATRA. One such receptor which may be responsible for the physiological outcome in 
our experiments is CI-MPR. To study the possible involvement of CI-MPR in the 
autophagosome maturation, we generated GFP and mRFP tagged CI-MPR fusion 
proteins. In our initial observation with colocalization studies using confocal 
microscopy revealed that CI-MPR is possibly involved in the autophagy process. 
Autophagosomes maturation process consists of multiple fusion events with 
endosomal compartments. These fusion events are thought to be responsible for the 
enrichment of autophagosomes with the vacuolar-type proton ATPase that mediates 
acidification of AUTs to amphisomes. Therefore, one possible explanation for 
increased AUT acidification by ATRA is that ATRA increases the fusion rate of 




transportation of the proton ATPase to autophagosome  directly from the Golgi 
network. In our subsequent CI-MPR knock down experim nts, Our data showing 
accumulation of nonacidified AUTs after silencing of CI-MPR strongly suggest the 
involvement of this receptor in AUT acidification. 
Based on electron microscopy, subcellular fractionati  studies, and 
immunofluorescence studies, localization of endogenus CI-MPR in a subset of 
autophagosomes was previously reported (Dunn, 1990; Jahreiss et al., 2008). In 
agreement with these studies, we found fluorescently tagged CI-MPR to acidified 
AUTs in increasing amounts under ATRA treatment, which suggest that CI-MPR also 
may be involved in delivering acid hydrolases to these structures, creating 
degradative autophagosomes. Knockdown of endogenous CI-MPR leads to 
substantial accumulation of nonacidified AUTs, which further suggests that 
acidification and possible acquisition of hydrolases may be an important event in the 
maturation of all AUTs and not only amphisomes, andit may be a requirement for 

























Autophagy is an intracellular catabolic process that responds with great 
sensitivity to nutrient availability, implying that certain macro- or micro-nutrients are 
involved. We found that retinoic acid promotes autophagosome maturation through a 
pathway independent from the classic nuclear retinoid receptors. Retinoic acid 
redistributes the cation-independent mannose-6-phopshate receptor from the trans-
Golgi region to maturing autophagosomal structures inducing their acidification. 
Manipulation of the autophagic activity by retinoids could have enormous health 
implications, since they are essential dietary compnents and frequently used 
pharmaceuticals. Although a better understanding of the affects of ATRA on 
autophagy utilizing CI-MPR had been obtained, at the time we started these studies 
the specific consequences of ATRA treatment were still not known. The goal of this 
work has been, therefore, to better understand the physiological outcomes of the 
ATRA treatment on autophagy and the underlying mechanism.  
Vitamin A is an essential dietary component that is involved in several 
physiological processes, such as reproduction, embryonic development, tissue 
remodeling, vision and immune function. Vitamin A deficiency has been extensively 
linked to increased oxidative stress, inflammation a d neurodegeneration and 
historically is considered as a nutritionally acquired immunodeficiency disease. 
Natural and synthetic retinoids play a major role in regulating cellular growth and 




mechanism however by which retinoids protect against viral and bacterial infections 
and suppress tumorigenesis is still unknown. 
Regulation of autophagy by macronutrient (proteins, carbohydrates, lipids) 
availability is well recognized. In general, amino acid deprivation directly triggers the 
autophagic response, whereas carbohydrates and lipids affect autophagy indirectly 
through the insulin/glucagon signaling pathway. With the exception of a few reports 
on vitamin D3 and selenium, the effect of micronutrients and particularly vitamin A 
on autophagy has not been studied. It is noteworthy, however, to mention that either 
vitamin A or autophagic deficiency can potentially lead to similar pathophysiological 
conditions. 
To investigate the role of retinoic acid in autophagy, we initially subjected 
transiently and stably CFP-LC3 transfected HeLa cells to low micromolar doses of 
ATRA (all-trans retinoic acid) and noticed a decrease in the steady state levels of 
CFP-LC3-labeled autophagosomes by confocal microscopy. However, we did not 
observe any changes in the ratio of CFP-LC3-I to CFP-LC3-II by western blotting. 
Both procedures, though, gave similar results when the cells were treated with 
rapamycin, which induces autophagosome biogenesis. To determine whether ATRA 
could affect the steady state levels of autophagosome  by inhibiting their formation, 
we examined the protein levels of Beclin 1, phosphorylated mTOR and 
phosphorylated Akt1 under retinoid stimulation. Our studies suggested that retinoids 
do not affect the early stages of autophagosome formation. However, it is well 
accepted in the field that, upon biogenesis, autophagosomes progress through a series 




Therefore, changes in the pH of the autophagosomal lumen or fusion with the acidic 
lysosomes could induce fluorescent quenching of CFP/G /EYFP fusion proteins. 
Indeed, treatment of mCherry-LC3 transfected cells (mCherry is acid resistant) with 
ATRA did not result in significant change in the number of autophagosomes/auto-
lysosomes. To further verify this observation, we subjected GFP-mCherry-LC3 (pH 
sensitive reporter) transfected cells to ATRA and observed a significant reduction in 
the ratio of yellow/red puncta. These observations suggested that ATRA either 
promotes autophagosome/lysosome fusion or induces autophagosome acidification 
(e.g., by the generation of amphisomes). It is worth mentioning that reliable markers 
to distinguish between early and maturing (acidifie) autophagosomes do not exist. In 
addition, the mechanism by which autophagosomes becom  acidified is not fully 
understood; however, fusion with late acidic endosomes has been suggested. 
In our efforts to determine the mechanism of retinoic acid-induced 
autophagosome maturation, we performed several studie  using specific antagonists 
and agonists of the classic retinoic acid receptors (RARs and RXRs). Our 
observations strongly suggested that the classic RARs and RXRs receptors do not 
mediate the effects of retinoids on autophagosome maturation. Recent evidence, 
though has suggested that other retinoid response pathways that are independent of 
the nuclear receptors may exist. Although the biological significance of retinoic acid 
binding to alternative intracellular sites is not understood, it was of interest to us that 
photoaffinity labeling studies have shown direct binding of ATRA to the cation-
independent mannose-6-phosphate/IGFII receptor (CI-MPR) with high affinity. CI-




that plays a fundamental role in endocytosis and degradation of extracellular ligands 
(IGF-II, uPAR), and sorting and transporting mannose-6-phosphate bearing 
glycoproteins (such as hydrolases) from the trans-Golgi network (TGN) to 
endosomes.  
To investigate potential effects of retinoids on the intracellular trafficking of 
CI-MPR, we prepared mGFP- and mRFP-tagged full-length CIMPR constructs. 
Under basal conditions, the fluorescent CI-MPR fusion proteins are mostly localized 
in the perinuclear TGN, some vesicular compartments a d the plasma membrane. 
Treatment with retinoids in parallel experiments induces significant redistribution of 
CI-MPR fusion proteins to peripheral vesicular struc ures that are not labeled with 
CFP-LC3 or LAMP-1-RFP (lysosomal marker) but are positive for mCherry-LC3. 
These data suggested that retinoic acid induces redistribution of CI-MPR into 
acidified autophagosomes. 
To further understand the role of CI-MPR in autophagosome maturation, we 
utilized siRNA-mediated silencing of endogenous CI-MPR levels. Knockdown of CI-
MPR leads to remarkable accumulation of nonacidifie immature autophagosomes 
and Rab9-labeled late endosomes, but has no effect on the abundance of lysosomes. 
In addition this effect cannot be reversed by retinoic acid treatment, further 
demonstrating that the effects of these compounds o autophagosome maturation are 
mediated through CI-MPR. Accumulation of early nonacidified autophagosomes in 
the absence of CI-MPR indicates the importance of this glycoprotein in 
autophagosome maturation, but also suggests that autophagosome acidification might 




required for acidification of a subset of late endosomes, which in turn mediate 
autophagosome maturation through fusion. Alternatively, direct translocation of CI-





Fig.26 Proposed Mechanism of autophagosome (AP) maturation by retinoids 
through redistribution of the cation-independent mannose-6 phosphate receptor 
(CI-MPR). Initial formation of APs takes place by engulfing of cargo within the 
phagophore (PG). The PG elongates and closes to form a vesicle through a process 
mediated by the LC3 conjugation system. APs then undergo maturation before fusion 
with lysosomes and formation of autolysosomes. This maturation process potentially 




acidification. This acidification can be accomplished by either fusion of APs with a 
subset of late endosomes and multivesicular bodies enriched in proton pumps to form 
amphisomes, or by direct translocation of the proton pump from the TGN to APs. 
Translocation of the proton pump and other hydrolytic enzymes relies on CI-MPR. 
Binding of retinoic acid to CI-MPR-enzyme complexes in the TGN induces their 
translocation to late endosomes (A) or APs (B) and promotes acidification.        
 
Pharmacological modulation of disrupted autophagic activity has been 
suggested as a strategy for therapies within a widespectrum of pathological situations 
including cancer, neurological diseases, premature aging and infectious diseases. 
Although retinoids are a multitargeting class of compounds that can modulate several 
physiological and cellular processes, we identified a novel mechanism involving the 
CI-MPR by which retinoids affect autophagy. This finding can lay the foundation for 
the development of new and specific retinoid analogues that could enhance or reduce 
autophagic activity.  
Future Prospective 
We provide here first line of evidences showing that ATRA interacts 
autophagy pathway by inducing autophagosome maturation. However, there are still 
many remaining questions and areas that require further characterization. An 
important remaining aspect that requires further investigation is the identification of 
the ATRA binding domain on CI-MPR. The extracellular domain of CI-MPR is 
composed of 15 homologous repeats, (independent structural units of 134-167 aa), 
displaying multifunctional binding properties. It can be carried out by generating 




repeats, and assess ATRA binding by photo-affinity labeling and co-
immunoprecipitation, and ATRA-mediated intracellular redistribution. After 
Generation of these targeted CI-MPR deletion constructs will be expressed in CI-
MPR negative cells. These experiments may shed light on to the retinoic binding sites 
on the CI-MPR and elucidate the mechanism of intracellular redistribution of the CI-
MPR by ATRA. These studies will provide crucial insights about the mechanism by 
which translocation of CI-MPR to AUTs induces maturion. 
As our results indicated that retinoids induces AUT acidification in a CI-
MPRdepended manner. Of great interest, would also be to analyze the consequences 
of ATRA induced AUT maturation on autophagic activity. To determine if this 
maturation event actually enhances autophagic activity, we will perform autophagic 
flux assays and correlate findings with morphological evaluation of the various 
autophagic compartments by EM. To determine if the ATRA-induced AUT 
maturation increases their fusion with lysosomes, we will perform in vitro fusion 
assays, and monitor AUT-LYS fusion with live cell imaging. Follow up studies 
should aim to characterize the unique proteome of AUTs in ATRA-treated cells under 
various experimental conditions, examine the interaction of individually identified 
proteins with CI-MPR and evaluate their effect on autophagy using established 
methods to measure AUTs, maturation status, and overall autophagic activity.  
Also, of particular interest would be to investigate whether autophagosome 
maturation by ATRA observed in the cultured cells ao occurs in vivo in a whole 




out throughout the course of this work, we intend to analyze in the transgenic animals 
the autophagic capabilities of different tissue. To determine the effect of retinoids on 
autophagy in vivo we will subject hemizygous GFP-LC3 transgenic (Tg) mice to diets 
that will induce VitA deficiency or non-toxic vitamin A excess at various stages of 
development. The mouse model will be particularly usef l to validate the existence of 
ATRA affects on autophagy in-vivo. Transgenic mice expressing GFP-LC3 (CAG-
GFP-LC3) have been used to detect autophagy systemically. However, GFP-LC3 
mice cannot distinguish autophagosome biogenesis and maturation events. Also these 
mice cannot detect autolysosome because GFP-LC3 loses fluorescence due to 
lysosomal acidic and degradative conditions.  
Regarding studying the acidification and maturation in vivo, we can utilize 
recently develop mCherry-LC3 mice transgenic mice. To resolve above mentioned 
problems with GFP-LC3 mice, recently transgenic mice ( MyHC-mCherry-LC3) 
expressing mCherry fused to LC3 under the control of myosin heavy chain promoter 
has been generated. These mice detect autophagy only in cardiomyocytes (Terada et 
al., 2010). mCherry is an improved-monomeric red-fluorescence protein and does not 
lose fluorescence under acidic condition. Thus, MyHC-mCherry-LC3 mice can 
detect not only autophagosome before fusion with lysosome but also autophagosome 
after fusion with lysosome. In conclusion, MyHC-mCherry-LC3 mice can be used in 
the future studies to detect both autophagosome and autolysosome. This will be an 
innovative approach to examine the role of autophagy in tissue specific manner. 
Furthermore, it will be more interesting to look in to the consequences of tissue 




system. To further analyze the physiological relevance of autophagy in different 
tissues, we will be looking in to the developing models in which autophagy can be 
studied in specific tissues. 
It would be very interesting to study if ATRA also affect other arms of 
autophagy like CMA. Interestingly, it was recently shown that retinoid compounds 
selective for particular RARα downstream pathways lead to the selective activation of 
CMA in the absence of detectable changes in other autophagic pathways (Anguiano 
et al., 2013). Furthermore, authors have demonstrated that chemical enhancement of 
CMA with these compounds renders cells more resistant to oxidative stress and 
proteotoxicity. These findings highlight the potential herapeutic applicability of these 
or related compounds in the treatment of chronic diseases that associate with loss of 
CMA activity. It would be very interesting to study if CI-MPR is also involved in the 
CMA activity under retinoid stimulation. 
Identification of the retinoid-binding domain is required to understand the 
mechanism of CI-MPR redistribution, and will aid in the design of better retinoid 
analogues with fewer side effects. AUT maturation is a poorly understood process, 
primarily due to lack of specific cellular markers. The observation that CI-MPR is 
critical for AUT acidification will aid in understanding the mechanism involved in 
AUT maturation, and provide means in identifying new markers. Several studies have 
suggested that reduced autophagy might be responsible for several age-related 
neurodegenerative diseases, autoimmune disorders, reduced immune function and 




enormous health implications, since they are essential dietary components and 
frequently used pharmaceuticals.  
In Summary, the knowledge we have acquired through the course of these studies will 
serve as assets as we attempt to learn more of the physiological importance of the 
nutrient regulation of the different autophagic pathways and contribution of their 
perturbation during various diseases. Also, by providing the novel mechanism of 
action for ATRA, it sheds light on potential mechanism of some of the existing 
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